0001161697-23-000627.txt : 20231215 0001161697-23-000627.hdr.sgml : 20231215 20231215161527 ACCESSION NUMBER: 0001161697-23-000627 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20231031 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUTRA CORP. CENTRAL INDEX KEY: 0001512886 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 274505461 STATE OF INCORPORATION: WY FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55077 FILM NUMBER: 231490503 BUSINESS ADDRESS: STREET 1: 54 SUGAR CREEK CENTER BLVD. STREET 2: SUITE 200 CITY: SUGAR LAND STATE: TX ZIP: 77478 BUSINESS PHONE: (702) 793-4121 MAIL ADDRESS: STREET 1: 54 SUGAR CREEK CENTER BLVD. STREET 2: SUITE 200 CITY: SUGAR LAND STATE: TX ZIP: 77478 10-Q 1 form_10-q.htm FORM 10-Q QUARTERLY REPORT FOR 10-31-2023
false 2024 Q3 --01-31 0001512886 Unlimited Unlimited P3Y 0001512886 2023-02-01 2023-10-31 0001512886 2023-12-15 0001512886 2023-10-31 0001512886 2023-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-01-31 0001512886 2022-02-01 2023-01-31 0001512886 2023-08-01 2023-10-31 0001512886 2022-08-01 2022-10-31 0001512886 2022-02-01 2022-10-31 0001512886 us-gaap:CommonStockMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0001512886 us-gaap:RetainedEarningsMember 2022-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-01-31 0001512886 2022-01-31 0001512886 us-gaap:CommonStockMember 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-04-30 0001512886 2022-04-30 0001512886 us-gaap:CommonStockMember 2022-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001512886 us-gaap:RetainedEarningsMember 2022-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-07-31 0001512886 2022-07-31 0001512886 us-gaap:CommonStockMember 2023-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001512886 us-gaap:RetainedEarningsMember 2023-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-01-31 0001512886 us-gaap:CommonStockMember 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-04-30 0001512886 2023-04-30 0001512886 us-gaap:CommonStockMember 2023-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001512886 us-gaap:RetainedEarningsMember 2023-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-07-31 0001512886 2023-07-31 0001512886 us-gaap:CommonStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-02-01 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-02-01 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-02-01 2022-04-30 0001512886 2022-02-01 2022-04-30 0001512886 us-gaap:CommonStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-07-31 0001512886 us-gaap:RetainedEarningsMember 2022-05-01 2022-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-05-01 2022-07-31 0001512886 2022-05-01 2022-07-31 0001512886 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001512886 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-08-01 2022-10-31 0001512886 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-02-01 2023-04-30 0001512886 2023-02-01 2023-04-30 0001512886 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001512886 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-05-01 2023-07-31 0001512886 2023-05-01 2023-07-31 0001512886 us-gaap:CommonStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-08-01 2023-10-31 0001512886 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-08-01 2023-10-31 0001512886 us-gaap:CommonStockMember 2022-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001512886 us-gaap:RetainedEarningsMember 2022-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-10-31 0001512886 2022-10-31 0001512886 us-gaap:CommonStockMember 2023-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001512886 us-gaap:RetainedEarningsMember 2023-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-10-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-02-01 2023-10-31 0001512886 us-gaap:EquipmentMember 2023-10-31 0001512886 ntrr:MrJimMember srt:ChiefExecutiveOfficerMember 2023-10-31 0001512886 ntrr:DeityCorporationMember 2023-10-31 0001512886 us-gaap:EquipmentMember 2023-01-31 0001512886 srt:ChiefExecutiveOfficerMember 2023-02-01 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember 2022-02-01 2022-10-31 0001512886 srt:ChiefExecutiveOfficerMember 2022-02-01 2023-01-31 0001512886 ntrr:MrJimMember srt:ChiefExecutiveOfficerMember 2023-02-01 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-01-31 0001512886 2022-03-11 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2020-01-31 0001512886 us-gaap:SeriesAPreferredStockMember ntrr:VIVISCorporationMember 2020-01-01 2020-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-07-31 0001512886 us-gaap:SeriesBPreferredStockMember ntrr:VIVISCorporationMember 2020-07-01 2020-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember ntrr:VIVISCorporationMember 2020-11-01 2020-11-30 0001512886 us-gaap:ConvertiblePreferredStockMember 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-01 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-13 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-12 2015-11-13 0001512886 us-gaap:SeriesFPreferredStockMember 2023-02-01 2023-10-31 0001512886 us-gaap:SeriesFPreferredStockMember srt:ChiefExecutiveOfficerMember 2021-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2022-10-31 0001512886 2022-02-23 0001512886 2022-02-21 2022-02-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 31, 2023

 

or

 

[_] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File Number: 0-55077

 

NEUTRA CORP.

(Exact name of registrant as specified in its charter)

 

Wyoming   27-4505461
(State or other jurisdiction of Incorporation or organization)   (I.R.S. Employer Identification Number)
     
54 Sugar Creek Center Blvd., Suite 200
Sugar Land, Texas		   77478
(Address of principal executive offices)   (Zip code)

 

Registrant’s telephone number, including area code: 702-793-4121

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

[X] Yes  [_] No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

[X] Yes  [_] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer [_] Accelerated filer [_]
  Non-accelerated filer [X] Smaller reporting company [X]
    Emerging growth company [_]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   [_]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

[_] Yes  [X] No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of December 15, 2023, 2,917,899,124 shares of common stock are issued and outstanding.

 

 

TABLE OF CONTENTS

 

PART I — FINANCIAL INFORMATION  
   
Item 1. Financial Statements 4
   
Consolidated Balance Sheets (unaudited) 4
   
Consolidated Statements of Operations (unaudited) 5
   
Consolidated Statements of Stockholders’ Deficit (unaudited) 6
   
Consolidated Statement of Changes in Mezzanine Equity(unaudited) 7
   
Consolidated Statements of Cash Flows (unaudited) 8
   
Notes to the Unaudited Consolidated Financial Statements 9
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14
   
Item 3. Quantitative and Qualitative Disclosures about Market Risk 16
   
Item 4. Controls and Procedures 16
   
PART II — OTHER INFORMATION  
   
Item 1. Legal Proceedings 17
   
Item 1A. Risk Factors 17
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 17
   
Item 3. Defaults upon Senior Securities 17
   
Item 4. Mine Safety Disclosures 17
   
Item 5. Other Information 17
   
Item 6. Exhibits 17
   
Signatures 18

 

- 2 -

Table of Contents

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 

Certain statements in this report contain or may contain forward-looking statements. These statements, identified by words such as “plan”, “anticipate”, “believe”, “estimate”, “should”, “expect” and similar expressions include our expectations and objectives regarding our future financial position, operating results and business strategy. These statements are subject to known and unknown risks, uncertainties and other factors, which may cause actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward - looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause our actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to, our ability to secure suitable financing to continue with our existing business or change our business and conclude a merger, acquisition or combination with a business prospect, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Readers should carefully review this report in its entirety, including but not limited to our financial statements and the notes thereto and the risks described in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023. We advise you to carefully review the reports and documents we file from time to time with the Securities and Exchange Commission (the “SEC”), particularly our quarterly reports on Form 10-Q and our current reports on Form 8-K. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.

 

OTHER PERTINENT INFORMATION

 

When used in this report, the terms, “we,” the “Company,” “our,” and “us” refers to Neutra Corp., a Wyoming corporation.

 

- 3 -

Table of Contents

 

PART I — FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NEUTRA CORP.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

               
    October 31,   January 31,  
    2023   2023  
    (UNAUDITED)   (AUDITED)  
               
CURRENT ASSETS              
Cash and cash equivalents   $ 692   $ 1,969  
Accounts Receivable     98     —  
Inventory     18,610     23,846  
Total current assets     19,400     25,815  
               
Property and equipment, net     7,544     49,360  
               
TOTAL ASSETS   $ 26,944   $ 75,175  
               
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT              
Current Liabilities              
Accounts payable and accrued expenses   $ 480,974   $ 516,890  
Accounts payable to related party     407,768     233,087  
Advances payable     3,450     3,450  
Advances payable to related party     12,314     2,314  
Dividends payable on Series G preferred stock     —     2,062  
Accrued interest payable     4,322     1,836  
Total current liabilities     908,828     759,639  
               
Notes payable, related party     54,156     54,156  
               
TOTAL LIABILITIES     962,984     813,795  
               
COMMITMENTS AND CONTINGENCIES              
               
MEZZANINE EQUITY              
Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively     —     35,200  
               
STOCKHOLDERS' DEFICIT              
Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively     2,917,899     2,743,575  
Preferred stock, $0.001 par value; 20,000,000 shares authorized:              
Series A convertible preferred stock; 50,000 shares issued and outstanding at October 31, 2023 and January 31, 2023     50     50  
Series B convertible preferred stock; 10,000 and 0 shares issued and outstanding at October 31, 2023 and January 31, 2023     10     10  
Series C convertible preferred stock; 40,000 shares issued and outstanding at October 31, 2023 and January 31, 2023     40     40  
Series E preferred stock, 1,000,000 shares issued and outstanding at October 31, 2023 and January 31, 2023     1,000     1,000  
Series F preferred stock, $0.001 par value; 1,000,000 shares issued and outstanding at October 31, 2023 and January 31, 2023     1,000     1,000  
Additional paid-in capital     7,751,840     7,889,555  
Preferred stock subscribed but not issued     50,000     50,000  
Accumulated deficit     (11,657,879 )   (11,459,050 )
               
TOTAL STOCKHOLDERS' DEFICIT     (936,040 )   (773,820 )
               
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT   $ 26,944   $ 75,175  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 4 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

                           
    Three Months Ended   Nine Months Ended  
    October 31,   October 31,  
    2023   2022   2023   2022  
                           
REVENUE   $ 1,311   $ 23,383   $ 11,478   $ 62,077  
Cost of goods sold     722     12,708     6,403     29,725  
                           
Gross margin     589     10,675     5,075     32,352  
                           
OPERATING EXPENSES                          
Depreciation     9,051     19,726     41,816     59,179  
Sales commissions     779     10,584     6,879     26,101  
General and administrative expenses     43,487     46,439     152,085     186,958  
Total operating expenses     53,317     76,749     200,780     272,238  
                           
LOSS FROM OPERATIONS     (52,728 )   (66,074 )   (195,705 )   (239,886 )
                           
OTHER INCOME (EXPENSE)                          
Interest expense     (2,258 )   (15,718 )   (2,486 )   (46,528 )
Total other income (expense)     (2,258 )   (15,718 )   (2,486 )   (46,528 )
                           
Net loss before income taxes     (54,986 )   (81,792 )   (198,191 )   (286,414 )
Provision for income taxes     —     —     (638 )   —  
Net loss     (54,986 )   (81,792 )   (198,829 )   (286,414 )
                           
Dividends on Series G convertible preferred stock     —     (573 )   —     (4,105 )
Deemed dividend on Series G convertible preferred stock     —     —     —     (10,200 )
                           
Net loss available to common shareholders   $ (54,986 ) $ (82,365 ) $ (198,829 ) $ (300,719 )
                           
Net loss per common share   $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 )
                           
Weighted average shares outstanding - basic and diluted     2,917,899,124     2,300,718,171     2,914,202,623     2,187,836,449  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 5 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED)

                                                                                       
        Series A                           Stock      
        Convertible   Series B   Series C   Series E   Series F   Additional       subscribed   Total  
    Common stock   Preferred Stock   Preferred Stock   Preferred Stock   Preferred Stock   Preferred Stock   paid-in   Accumulated   but not   Equity  
    Shares   Par   Shares   Par   Shares   Par   Shares   Par   Shares   Par   Shares   Par   capital   Deficit   issued   (Deficit)  
                                                                                       
Balance, January 31, 2022   1,782,073,799   $ 1,782,074   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,824,982   $ (10,882,188 ) $ —   $ (1,273,032 )
Common stock issued for preferred stock conversions   425,622,150     425,622   —     —   —     —   —     —   —     —   —     —     (199,110 )   —     —     226,512  
Preferred stock subscribed but not issued   —     —   —     —   —     —   —     —   —     —   —     —     —     —     50,000     50,000  
Dividends on Series G preferred stock   —     —   —     —   —     —   —     —   —     —   —     —     —     (2,429 )   —     (2,429 )
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (107,196 )         (107,196 )
Balance, April 30, 2022   2,207,695,949   $ 2,207,696   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,625,872   $ (10,991,813 ) $ 50,000   $ (1,106,145 )
Common stock issued for preferred stock conversions   93,022,222     93,022   —     —   —     —   —     —   —     —   —     —     (59,535 )   —     —     33,487  
Dividends on Series G preferred stock   —     —   —     —   —     —   —     —   —     —   —     —     —     (1,103 )   —     (1,103 )
Deemed dividend on Series G convertible preferred stock   —     —   —     —   —     —   —     —   —     —   —     —     —     (10,200 )   —     (10,200 )
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (97,426 )         (97,426 )
Balance, July 31, 2022   2,300,718,171   $ 2,300,718   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,566,337   $ (11,100,542 ) $ 50,000   $ (1,181,387 )
Dividends on Series G convertible preferred stock   —     —   —     —   —     —   —     —   —     —   —     —     —     (573 )   —     (573 )
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (81,792 )         (81,792 )
Balance, October 31, 2022   2,300,718,171   $ 2,300,718   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,566,337   $ (11,182,907 ) $ 50,000   $ (1,263,752 )
                                                                                       
                                                                                       
Balance, January 31, 2023   2,743,575,314   $ 2,743,575   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,889,555   $ (11,459,050 ) $ 50,000   $ (773,820 )
Common stock issued for preferred stock conversions   174,323,810     174,324   —     —   —     —   —     —   —     —   —     —     (137,715 )   —     —     36,609  
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (71,996 )   —     (71,996 )
Balance, April 30, 2023   2,917,899,124   $ 2,917,899   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,751,840   $ (11,531,046 ) $ 50,000   $ (809,207 )
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (71,847 )   —     (71,847 )
Balance, July 31, 2023   2,917,899,124   $ 2,917,899   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,751,840   $ (11,602,893 ) $ 50,000   $ (881,054 )
Net loss   —     —   —     —   —     —   —     —   —     —   —     —     —     (54,986 )   —     (54,986 )
Balance, October 31, 2023   2,917,899,124   $ 2,917,899   50,000   $ 50   10,000   $ 10   40,000   $ 40   1,000,000   $ 1,000   1,000,000   $ 1,000   $ 7,751,840   $ (11,657,879 ) $ 50,000   $ (936,040 )

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 6 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY

(UNAUDITED)

             
  Series G Preferred Stock  
  Shares   Amount  
         
Balance, January 31, 2023   35,200   $ 35,200  
             
Series G preferred stock converted to common stock   (35,200 )   (35,200 )
             
Balance, October 31, 2023   —   $ —  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 7 -

Table of Contents

 

NEUTRA CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

               
    Nine Months Ended  
    October 31,  
    2023   2022  
               
CASH FLOW FROM OPERATING ACTIVITIES:              
Net loss   $ (198,829 ) $ (286,414 )
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation     41,816     59,179  
Changes in operating assets and liabilities              
Accounts Receivable     (98 )   —  
Inventory     5,236     (26,810 )
Accounts payable and accrued liabilities     21,637     (23,271 )
Accounts payable to related party     116,475     76,332  
Accrued interest payable     2,486     46,228  
NET CASH USED IN OPERATING ACTIVITIES     (11,277 )   (154,756 )
               
CASH FLOWS FROM FINANCING ACTIVITIES              
Stock subscriptions received     —     50,000  
Proceeds from sale of Series G convertible preferred stock     —     50,000  
Proceeds from advance from related party     10,000     —  
Proceeds from issuance of note payable     —     60,000  
Repayments on notes payable     —     (5,844 )
NET CASH PROVIDED BY FINANCING ACTIVITIES     10,000     154,156  
               
NET CHANGE IN CASH AND CASH EQUIVALENTS     (1,277 )   (600 )
               
Cash and cash equivalents at beginning of period     1,969     1,056  
               
Cash and cash equivalents at end of period   $ 692   $ 456  
               
Cash paid during the period for:              
Interest   $ —   $ —  
Taxes   $ —   $ —  
               
Noncash investing and financing transactions:              
Conversion of Series G preferred stock   $ 36,609   $ 250,000  
Dividends on mezzanine equity   $ —   $ 4,105  
Deemed dividend on mezzanine equity   $ —   $ 10,200  
Expenses paid on the Company’s behalf   $ 58,206   $ —  

 

The accompanying footnotes are an integral part of these unaudited consolidated financial statements.

 

- 8 -

Table of Contents

 

NEUTRA CORP.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2023

 

Note 1. Background Information

 

Neutra Corp. was incorporated in Nevada on January 11, 2011, to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. We have established a fiscal year end of January 31.

 

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.

 

Note 2. Going Concern

 

For the nine months ended October 31, 2023, the Company had a net loss of $198,829 and did not have positive cash flow from operations. As of October 31, 2023, the Company has negative working capital of $889,428. We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.

 

These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.

 

Management has plans to address the Company’s financial situation as follows:

 

In the near term, management plans to continue to focus on raising the funds necessary to implement the Company’s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raises doubts about the Company’s ability to continue as a going concern.

 

In the long term, management believes that the Company’s projects and initiatives will be successful and will provide cash flow to the Company that will be used to finance the Company’s future growth. However, there can be no assurances that the Company’s planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.

 

Note 3. Significant Accounting Policies

 

The significant accounting policies that the Company follows are:

 

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023, and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).

 

The results of operations for the nine month period ended October 31, 2023, are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.

 

Basis of Presentation

 

The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.

 

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Inventory

 

Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of October 31, 2023, and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Property and Equipment, net

 

Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over three years beginning when the asset is put in service. For the nine months ended October 31, 2023, and 2022, the Company recognized depreciation expense of $41,816 and $59,179, respectively.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

• Identification of the contract with a customer
   
• Identification of the performance obligations in the contract
   
• Determination of the transaction price
   
• Allocation of the transaction price to the performance obligations in the contract
   
• Recognition of revenue when, or as, the Company satisfies a performance obligation

 

- 10 -

Table of Contents

 

Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Cost of Sales

 

Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.

 

Earnings (Loss) per Common Share

 

We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.

 

Commitments and Contingencies

 

The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

 

As discussed in more detail in Note 5, the Company agreed to pay 60% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $250,000 is paid to Mr. Jim, at which point he will be entitled to 20% of revenue from Deity Corporation.

 

There were no other known commitments or contingencies as of October 31, 2023, and January 31, 2023.

 

Mezzanine equity

 

Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.

 

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

 

Recently Adopted Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. 

 

Note 4. Property and equipment, net

 

Property and equipment consist of the following:

 

    October 31, 2023   January 31, 2023  
Equipment   $ 236,717   $ 236,717  
Total property and equipment     236,717     236,717  
Less: accumulated depreciation     (229,173 )   (187,357 )
Property and equipment, net   $ 7,544   $ 49,360  

 

Note 5. Related Party Transactions

 

During the nine months ended October 31, 2023, and 2022, we incurred salary expense of $75,000 to our CEO, Sydney Jim. In addition, we incurred commission expense of $6,879 and $26,101 during the nine months ended October 31, 2023, and 2022 to Mr. Jim and owed a total of $41,475 and $34,596 in accrued commissions as of October 31, 2023, and January 31, 2023, respectively. During the nine months ended October 31, 2023, Mr. Jim paid expenses of $41,253 on behalf of the Company.

 

As of October 31, 2023, and January 31, 2023, we owed Mr. Jim, or entities controlled by him, $407,768 and $233,087 which is recorded on the balance sheet in “Accounts Payable – Related Party”, respectively, and $12,314 and $2,314 in “Advances payable to related party”, respectively. This balance includes the commissions payable to Mr. Jim described above.

 

During the nine months ended October 31, 2023, an investor advanced $10,000 to the Company. This advance is unsecured, non-interest bearing and due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of October 31, 2023, the note principal balance was $54,156 and accrued interest was $4,322. The Company has not made all the required monthly payments under the note agreement to date.

 

During the year ended January 31, 2022, the Company acquired the assets of Deity Corporation, a Texas corporation which the Sydney Jim, the Company’s CEO, had a controlling interest in that will produce hemp and cannabis products. The transaction was considered an asset acquisition, as there were no operations of Deity Corporation prior to the transaction. The Company received the formulas for certain hemp and cannabis-based products and a website to market the products that will be produced. In exchange, the Company will pay Mr. Jim 60% of the revenue from Deity Corporation sales until a total of $250,000 is reached, at which point the Company will pay 20% of Deity Corporation revenue to Mr. Jim.

 

Note 6. Advances and Notes Payable

 

As of October 31, 2023, and January 31, 2023, we had amounts due under advances of $3,450 at each period. These advances are not collateralized, non-interest bearing and are due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of October 31, 2023, the note principal balance was $54,156 and accrued interest was $4,322.

 

- 12 -

Table of Contents

 

Note 7. Shareholders’ Equity

 

Series A Preferred Stock. In January 2020, our board of directors designated 50,000 shares of our preferred stock as Series A Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series A Preferred Stock has a stated value of $5 per share. The Series A Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. The holders of the Series A Preferred Stock have the option to convert each share into 800 shares of common stock of the Company. As of October 31, 2023, and January 31, 2023, there are 50,000 shares of Series A Preferred Stock outstanding.

 

Series B Preferred Stock. In July 2020, our board of directors designated 10,000 shares of our preferred stock as Series B Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series B Preferred Stock has a stated value of $5 per share. The Series B Preferred Stock is entitled to receive dividends of 0.4% of the net profit of VIVIS Corporation. Holders of the Series B Preferred Stock have the option to convert each share into 800 shares of common stock. During the year ended January 31, 2021, the Company subscribed 10,000 shares of Series B Preferred Stock for cash proceeds of $50,000. The shares were issued during the year ended January 31, 2022. As of October 31, 2023, and January 31, 2023, there are 10,000 shares of Series B Preferred Stock outstanding.

 

Series C Preferred Stock. In November 2020, our board of directors designated 40,000 shares of our preferred stock as Series C Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series C Preferred Stock has a stated value of $5 per share. The Series C Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. After the Series C Preferred Stock has received cumulative dividends of $500,000, the dividend rate will reduce to 1%. Holders of the Series C Preferred Stock have the option to convert each share into 38 shares of common stock. During the year ended January 31, 2021, the Company subscribed 40,000 shares of Series B Preferred Stock for cash proceeds of $200,000. The shares were issued during the year ended January 31, 2022. As of October 31, 2023, and January 31, 2023, there are 40,000 shares of Series C Preferred Stock outstanding.

 

Series E preferred stock issued for services

 

On November 13, 2015, our board of directors designated 1,000,000 shares of our preferred stock as Series E Preferred Stock. The Series E Preferred Stock is subordinated to our common stock. It does not receive dividends and does not participate in equity distributions. The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company. As of October 31, 2023, and January 31, 2023, there are 1,000,000 shares Series E Preferred Stock outstanding. Dividends, when, as and if declared by the Board of Directors, shall be paid out of funds at the time legally available for such purposes.

 

Series F preferred stock issued for services

 

The Series F Preferred Stock is subordinated to our common stock and superior to all shares of Preferred Stock. It does not receive dividends and does not participate in equity distributions. The Series F Preferred stock retains 2/3 of the voting rights in the company. During the year ended January 31, 2021, the Company issued 1,000,000 shares of Series F Preferred Stock to Sydney Jim, our CEO, in exchange for services. As of the date of this report, there are 1,000,000 shares Series F Preferred Stock outstanding. As of October 31, 2023, and January 31, 2023, there are 1,000,000 shares of Series F Preferred Stock outstanding.

 

Series G convertible preferred stock

 

During the nine months ended October 31, 2023, the Company the holder of the Series G convertible preferred stock converted 35,200 shares and accrued dividends of $1,408 into 174,323,810 shares of common stock. During the nine months ended October 31, 2022, the Company accrued dividends of $3,532, and the holder of the Series G convertible preferred stock converted 250,000 shares and accrued dividends of $10,000 into 518,644,372 shares of common stock. The conversions were in accordance with the terms of the agreement and no gain or loss was recognized. As of October 31, 2023, there were no shares of Series G convertible preferred stock outstanding.

 

Preferred Stock Subscription

 

On February 23, 2022, the Company sold 10,000 shares of preferred stock not yet designated for cash proceeds of $50,000.

 

- 13 -

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and plan of operations should be read in conjunction with our financial statements and related notes appearing elsewhere herein. This discussion and analysis contains forward-looking statements including information about possible or assumed results of our financial conditions, operations, plans, objectives, and performance that involve risk, uncertainties, and assumptions. The actual results may differ materially from those anticipated in such forward-looking statements. For example, when we indicate that we expect to increase our product sales and potentially establish additional license relationships, these are forward-looking statements. The words expect, anticipate, estimate or similar expressions are also used to indicate forward-looking statements.

 

Background of our Company

 

Neutra Corp. was incorporated in Florida on January 11, 2011. On October 5, 2015, we reincorporated from Florida to Nevada. On August 16, 2019, we reincorporated from Nevada to Wyoming. The reincorporation was approved by our board of directors and by the holders of a majority of the voting rights for our common stock. There was no change in share ownership as a result of the reincorporation. Our authorized shares in the Wyoming corporation are unlimited shares of common stock and 20,000,000 shares of preferred stock.

 

We have established a fiscal year end of January 31.

 

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.

 

We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.

 

Plan of Operations

 

We believe we do not have adequate funds to fully execute our business plan for the next twelve months unless we obtain additional funding. However, should we not raise this capital, we will allocate our funding to first assure that all State, Federal and SEC requirements are met.

 

As of October 31, 2023, we had cash on hand of $692.

 

We intend to pursue capital through public or private financing, as well as borrowing and other sources in order to finance our business activities. We cannot guarantee that additional funding will be available on favorable terms, if at all. If adequate funds are not available, then our ability to continue our operations may be significantly hindered.

 

Critical Accounting Policies

 

We prepare our consolidated financial statements in conformity with GAAP, which requires management to make certain estimates and apply judgments. We base our estimates and judgments on historical experience, current trends, and other factors that management believes to be important at the time the consolidated financial statements are prepared. On a regular basis, we review our accounting policies and how they are applied and disclosed in our consolidated financial statements.

 

While we believe that the historical experience, current trends and other factors considered support the preparation of our consolidated financial statements in conformity with GAAP, actual results could differ from our estimates and such differences could be material.

 

For a full description of our critical accounting policies, please refer to Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report for the year ended January 31, 2023, on Form 10-K.

 

- 14 -

Table of Contents

 

Results of Operations

 

Three months ended October 31, 2023 compared to the three months ended October 31, 2022.

 

Revenue and Cost of Goods Sold

 

During the three months ended October 31, 2023, we recognized revenue of $1,311 and cost of goods sold of $722 related to the sales of CBD products. During the three months ended October 31, 2022, we recognized revenue of $23,383 and cost of goods sold of $12,708 related to the sales of CBD products. The decrease in revenue compared to the prior year is due to a slowdown in current economic conditions.

 

Depreciation

 

We recognized depreciation expense of $9,051 and $19,726 for the three months ended October 31, 2023, and 2022, respectively, related to the Company’s property and equipment.

 

General and Administrative Expenses

 

We recognized general and administrative expenses of $43,487 and $46,439 for the three months ended October 31, 2023, and 2022, respectively. The decrease is primarily related to the decrease in wages and professional fees.

 

Interest Expense

 

Interest expense was $2,258 and $15,718 for the three months ended October 31, 2023, and 2022, respectively. The decrease in interest expense was related to the settlement of outstanding convertible notes payable in the prior year.

 

Net Loss

 

We incurred a net loss of $54,986 for the three months ended October 31, 2023, as compared to $81,792 for the comparable period of 2022.

 

Nine months ended October 31, 2023, compared to the nine months ended October 31, 2022.

 

Revenue and Cost of Goods Sold

 

During the nine months ended October 31, 2023, we recognized revenue of $11,478 and cost of goods sold of $6,403 related to the sales of CBD products. During the nine months ended October 31, 2022, we recognized revenue of $62,077 and cost of goods sold of $29,725 related to the sales of CBD products. The decrease in revenue compared to the prior year is due to a slowdown in current economic conditions.

 

Depreciation

 

We recognized depreciation expense of $41,816 and $59,179 for the nine months ended October 31, 2023, and 2022 related to the Company’s property and equipment.

 

General and Administrative Expenses

 

We recognized general and administrative expenses of $152,085 and $186,958 for the nine months ended October 31, 2023, and 2022, respectively. The decrease is primarily related to the decrease in wages and professional fees.

 

Interest Expense

 

Interest expense was $2,486 and $46,528 for the nine months ended October 31, 2023, and 2022, respectively. The decrease in interest expense was related to the settlement of outstanding convertible notes payable in the prior year.

 

Net Loss

 

We incurred a net loss of $198,829 for the nine months ended October 31, 2023, as compared to $286,414 for the comparable period of 2022.

 

- 15 -

Table of Contents

 

Liquidity and Capital Resources

 

At October 31, 2023, we had cash on hand of $692. We have working capital deficit of $889,428. Net cash used in operating activities for the nine months ended October 31, 2023, was $11,277. The Company had net cash provided by financing activities of $10,000 for the nine months ended October 31, 2023, with $10,000 of proceeds from advances from related party. Cash on hand is not adequate to fund our operations for the next twelve months. We do not expect to achieve positive cash flow from operating activities in the near future. We will require additional cash in order to implement our business plan. There is no guarantee that we will be able to attain fund when we need them or that funds will be available on terms that are acceptable to us. We have no material commitments for capital expenditures as of October 31, 2023.

 

Additional Financing

 

Additional financing is required to continue operations. Although actively searching for available capital, we do not have any current arrangements for additional outside sources of financing and cannot provide any assurance that such financing will be available.

 

Off Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

This item is not applicable to smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Report on Internal Control over Financial Reporting

 

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of October 31, 2023. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of October 31, 2023, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed by us under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

1. As of October 31, 2023, we did not maintain effective controls over the control environment. Specifically, we have not developed and effectively communicated to our employees our accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.
   
2. As of October 31, 2023, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.
   
3. As of October 31, 2023, we did not maintain effective controls over transactions with related parties. Specifically, controls were not designed and in place to ensure that all transactions with related parties were captured and tracked in our financial statements. The Company has no formal process related to the identification and approval of related party transactions. Management has determined that this control deficiency constitutes a material weakness.

 

Our management, including our principal executive officer and principal financial officer, who is the same person, does not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

- 16 -

Table of Contents

 

Change in Internal Controls Over Financial Reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

PART II — OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We know of no material, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered beneficial shareholder are an adverse party or has a material interest adverse to us.

 

ITEM 1A. RISK FACTORS

 

This item is not applicable to smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

We have not defaulted upon senior securities.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

This item is not applicable to the Company.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit No. Description
3.1 Articles of Incorporation (1)
3.2 Bylaws (1)
14.1 Code of Ethics (1)
21 Subsidiaries of the Registrant (2)
31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial and accounting officer. (2)
32.1 Section 1350 Certification of principal executive officer and principal financial accounting officer. (2)
101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (3)
101.SCH Inline XBRL Taxonomy Extension Schema Document (3)
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document (3)
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document (3)
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document (3)
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document (3)
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). (3)

__________

(1) Incorporated by reference to our Form S-1 filed with the Securities and Exchange Commission on February 24, 2011.
(2) Filed or furnished herewith.
(3) In accordance with Regulation S-T, the Interactive Data Files in Exhibit 101 to the Quarterly Report on Form 10-Q shall be deemed “furnished” and not “filed.”

 

- 17 -

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Neutra Corp.
   
   
Date: December 15, 2023 BY: /s/ Sydney Jim
  Sydney Jim
 

President, Secretary, Treasurer, Principal Executive Officer,

Principal Financial and Accounting Officer, and Sole Director

 

- 18 -

 EX-21 2 ex_21.htm SUBSIDIARIES OF THE REGISTRANT

 

Exhibit 21

 

SUBSIDIARIES OF THE REGISTRANT

 

 

Diamond Anvil Designs, LLC, a Texas limited-liability corporation, is a wholly owned subsidiary of Neutra Corp.

 

Vivis Corporation, a Wyoming corporation, is a wholly owned subsidiary of Neutra Corp.

 

Deity Corporation, a Texas corporation, is a wholly owned subsidiary of Neutra Corp.

 

 EX-31 3 ex_31-1.htm RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION

 

Exhibit 31.1

 

RULE 13A-14(A)/15D-14(A) CERTIFICATION

 

I, Sydney Jim, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the period ended October 31, 2023 of Neutra Corp.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

   
Date: December 15, 2023 BY: /s/ Sydney Jim
  Sydney Jim
  President, Secretary, Treasurer, Principal Executive Officer,
Principal Financial and Accounting Officer and Sole Director

 

 EX-32 4 ex_32-1.htm SECTION 1350 CERTIFICATION

 

Exhibit 32.1

 

SECTION 1350 CERTIFICATION

 

In connection with the quarterly report of Neutra Corp. (the “Company”) on Form 10-Q for the period ended October 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, Sydney Jim, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: December 15, 2023 BY: /s/ Sydney Jim
  Sydney Jim
  President, Secretary, Treasurer, Principal Executive Officer,
Principal Financial and Accounting Officer and Sole Director

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 EX-101.SCH 5 ntrr-20231031.xsd INLINE XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Background Information link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property and equipment, net link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Advances and Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Shareholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Property and equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Property and equipment consist of the following: (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Advances and Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Shareholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ntrr-20231031_cal.xml INLINE XBRL CALCULATION FILE EX-101.DEF 7 ntrr-20231031_def.xml INLINE XBRL DEFINITION FILE EX-101.LAB 8 ntrr-20231031_lab.xml INLINE XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series E Preferred Stock [Member] Series F Preferred Stock [Member] Series G Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Stock Subscribed but Not Issued [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Related Party, Type [Axis] Mr Jim [Member] Title of Individual [Axis] Chief Executive Officer [Member] Deity Corporation [Member] Balance Sheet Location [Axis] Accounts Payable Related Party and Advances Payable to Related Party [Member] Consolidated Entities [Axis] VIVIS Corporation [Member] Convertible Preferred Stock [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] CURRENT ASSETS Cash and cash equivalents Accounts Receivable Inventory Total current assets Property and equipment, net TOTAL ASSETS LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses Accounts payable to related party Advances payable Advances payable to related party Dividends payable on Series G preferred stock Accrued interest payable Total current liabilities Notes payable, related party TOTAL LIABILITIES COMMITMENTS AND CONTINGENCIES MEZZANINE EQUITY Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively STOCKHOLDERS' DEFICIT Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively Preferred stock, value Additional paid-in capital Preferred stock subscribed but not issued Accumulated deficit TOTAL STOCKHOLDERS' DEFICIT TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT Preferred stock, par value (in dollars per share) Preferred stock, issued Preferred stock, outstanding Common stock, par value (in dollars per share) Common stock, shares authorized, unlimited Common stock, issued Common stock, outstanding Preferred stock, authorized Income Statement [Abstract] REVENUE Cost of goods sold Gross margin OPERATING EXPENSES Depreciation Sales commissions General and administrative expenses Total operating expenses LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Interest expense Total other income (expense) Net loss before income taxes Provision for income taxes Net loss Dividends on Series G convertible preferred stock Deemed dividend on Series G convertible preferred stock Net loss available to common shareholders Net loss per common share Weighted average shares outstanding - basic and diluted Beginning balance, value Beginning balance (in shares) Common stock issued for preferred stock conversions Common stock issued for preferred stock conversions (in shares) Preferred stock subscribed but not issued Dividends on Series G preferred stock Net loss Dividends on Series G convertible preferred stock Ending balance (in shares) Ending balance, value Series G preferred stock converted to common stock Series G Preferred Stock Converted to Common Stock Statement of Cash Flows [Abstract] CASH FLOW FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Changes in operating assets and liabilities Accounts Receivable Inventory Accounts payable and accrued liabilities Accounts payable to related party Accrued interest payable NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Stock subscriptions received Proceeds from sale of Series G convertible preferred stock Proceeds from advance from related party Proceeds from issuance of note payable Repayments on notes payable NET CASH PROVIDED BY FINANCING ACTIVITIES NET CHANGE IN CASH AND CASH EQUIVALENTS Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash paid during the period for: Interest Taxes Noncash investing and financing transactions: Conversion of Series G preferred stock Dividends on mezzanine equity Deemed dividend on mezzanine equity Expenses paid on the Company’s behalf Organization, Consolidation and Presentation of Financial Statements [Abstract] Background Information Going Concern Accounting Policies [Abstract] Significant Accounting Policies Property, Plant and Equipment [Abstract] Property and equipment, net Related Party Transactions [Abstract] Related Party Transactions Debt Disclosure [Abstract] Advances and Notes Payable Equity [Abstract] Shareholders’ Equity Interim Financial Statements Basis of Presentation Consolidated Financial Statements Use of Estimates Inventory Property and Equipment, net Revenue Recognition Earnings (Loss) per Common Share Commitments and Contingencies Mezzanine equity Subsequent events Recently Adopted Accounting Pronouncements Property and equipment consist of the following: Net loss Working capital Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Valuation allowance recognized Useful life Revenue, remaining performance obligation, percentage Total property and equipment Less: accumulated depreciation Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Salary expense Commission expense Accrued commission Expenses paid Accounts payable - related party Investor advance Loan agreement Unsecured loan interest Monthly interest payment Principal balance Accrued interest Revenue obligation from Deity Corporation before sales threshold, percentage Revenue obligation from Deity Corporation sales threshold Revenue obligation from Deity Corporation after sales threshold, percentage Unsecured loan intrest Monthly intrest payment Loan agreement Accrued interest Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock, dividend rate, percentage Prefered stock converted into common stock Number of shares sold Cash proceeds Shares outstanding Cumulative dividends received Description of voting rights Prefered stock converted into common stock Accrured dividends Dividends payable Cash proceeds The element represents mezzanine equity policy text block. The element represents recently adopted accounting pronouncements policy text block. The element represents unpaid compensation. The element represents accounts payable related party and advances payable to related party member. The element represents mr jim member. The element represents deity corporation member. The element represents advances payable. The element represents v i v i s corporation member. The element represents prefered stock converted into common stock. The element represents dividends payable current and noncurrent1. The element represents prefered stock converted into common stock1. The element represents loan agreement. The element represents unsecured loan intrest. The element represents monthly intrest payment. The element represents advances payable to related party. The element represents series g preferred stock. The element represents stock subscribed but not issued member. The element represents deemed dividend on series g preferred stock. The element represents series g preferred stock converted to common stock. The element represents stock subscriptions received. The element represents proceeds from advance from related party. The element represents series g preferred stock converted to common stock1. The element represents working capital. The element represents earnings loss per share basic and diluted. The element represents total weighted average number of share outstanding basic and diluted. The element represents conversionof series G preferred stock. The element represents other liability current related party. The element represents preferred stock shares outstanding1. The element represents expenses paid on companys behalf. The element represents interim financial statements policy text block. The element represents deemed dividend on series g convertible preferred stocks. The element represents operating income expense. The element represents deemed dividend on series g convertible preferred stock. Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Income Expense Operating Income (Loss) Interest Expense Other Nonoperating Income (Expense) Income Tax Expense (Benefit) Dividends, Preferred Stock Net Income (Loss) Available to Common Stockholders, Basic Shares, Outstanding Stock Issued During Period, Value, Issued for Services Depreciation [Default Label] Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable, Related Parties Increase (Decrease) in Interest Payable, Net Net Cash Provided by (Used in) Operating Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Property, Plant and Equipment Disclosure [Text Block] Inventory Finished Goods, Policy [Policy Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Financing Receivable, Accrued Interest, Writeoff Prefered Stock Converted into Common Stock Proceeds from Issuance of Preferred Stock and Preference Stock EX-101.PRE 9 ntrr-20231031_pre.xml INLINE XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
 9 Months Ended
Oct. 31, 2023
Dec. 15, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Oct. 31, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --01-31  
Entity File Number 0-55077  
Entity Registrant Name NEUTRA CORP.  
Entity Central Index Key 0001512886  
Entity Tax Identification Number 27-4505461  
Entity Incorporation, State or Country Code WY  
Entity Address, Address Line One 54 Sugar Creek Center Blvd.  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town Sugar Land  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 77478  
City Area Code 702  
Local Phone Number 793-4121  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   2,917,899,124
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Oct. 31, 2023
Jan. 31, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 692 $ 1,969
Accounts Receivable 98
Inventory 18,610 23,846
Total current assets 19,400 25,815
Property and equipment, net 7,544 49,360
TOTAL ASSETS 26,944 75,175
Current Liabilities    
Accounts payable and accrued expenses 480,974 516,890
Accounts payable to related party 407,768 233,087
Advances payable 3,450 3,450
Advances payable to related party 12,314 2,314
Dividends payable on Series G preferred stock 2,062
Accrued interest payable 4,322 1,836
Total current liabilities 908,828 759,639
Notes payable, related party 54,156 54,156
TOTAL LIABILITIES 962,984 813,795
Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively 35,200
STOCKHOLDERS' DEFICIT    
Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively 2,917,899 2,743,575
Additional paid-in capital 7,751,840 7,889,555
Preferred stock subscribed but not issued 50,000 50,000
Accumulated deficit (11,657,879) (11,459,050)
TOTAL STOCKHOLDERS' DEFICIT (936,040) (773,820)
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT 26,944 75,175
Series A Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 50 50
TOTAL STOCKHOLDERS' DEFICIT 50 50
Series B Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 10 10
TOTAL STOCKHOLDERS' DEFICIT 10 10
Series C Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 40 40
TOTAL STOCKHOLDERS' DEFICIT 40 40
Series E Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 1,000 1,000
TOTAL STOCKHOLDERS' DEFICIT 1,000 1,000
Series F Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT    
Preferred stock, value 1,000 1,000
TOTAL STOCKHOLDERS' DEFICIT $ 1,000 $ 1,000
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares
 9 Months Ended 12 Months Ended
Oct. 31, 2023
Jan. 31, 2023
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized, unlimited Unlimited Unlimited
Common stock, issued 2,917,899,124 2,743,575,314
Common stock, outstanding 2,917,899,124 2,743,575,314
Preferred stock, authorized 20,000,000 20,000,000
Series G Preferred Stock [Member]    
Preferred stock, par value (in dollars per share) $ 1.00 $ 1.00
Preferred stock, issued 0 35,200
Preferred stock, outstanding 0 35,200
Series A Preferred Stock [Member]    
Preferred stock, issued 50,000 50,000
Preferred stock, outstanding 50,000 50,000
Series B Preferred Stock [Member]    
Preferred stock, issued 10,000 0
Preferred stock, outstanding 10,000 0
Series C Preferred Stock [Member]    
Preferred stock, issued 40,000 40,000
Preferred stock, outstanding 40,000 40,000
Series E Preferred Stock [Member]    
Preferred stock, issued 1,000,000 1,000,000
Preferred stock, outstanding 1,000,000 1,000,000
Series F Preferred Stock [Member]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, issued 1,000,000 1,000,000
Preferred stock, outstanding 1,000,000 1,000,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2023
Oct. 31, 2022
Income Statement [Abstract]        
REVENUE $ 1,311 $ 23,383 $ 11,478 $ 62,077
Cost of goods sold 722 12,708 6,403 29,725
Gross margin 589 10,675 5,075 32,352
OPERATING EXPENSES        
Depreciation 9,051 19,726 41,816 59,179
Sales commissions 779 10,584 6,879 26,101
General and administrative expenses 43,487 46,439 152,085 186,958
Total operating expenses 53,317 76,749 200,780 272,238
LOSS FROM OPERATIONS (52,728) (66,074) (195,705) (239,886)
OTHER INCOME (EXPENSE)        
Interest expense (2,258) (15,718) (2,486) (46,528)
Total other income (expense) (2,258) (15,718) (2,486) (46,528)
Net loss before income taxes (54,986) (81,792) (198,191) (286,414)
Provision for income taxes (638)
Net loss (54,986) (81,792) (198,829) (286,414)
Dividends on Series G convertible preferred stock (573) (4,105)
Deemed dividend on Series G convertible preferred stock (10,200)
Net loss available to common shareholders $ (54,986) $ (82,365) $ (198,829) $ (300,719)
Net loss per common share $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average shares outstanding - basic and diluted 2,917,899,124 2,300,718,171 2,914,202,623 2,187,836,449
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Stock Subscribed but Not Issued [Member]
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Series C Preferred Stock [Member]
Series E Preferred Stock [Member]
Series F Preferred Stock [Member]
Total
Beginning balance, value at Jan. 31, 2022 $ 1,782,074 $ 7,824,982 $ (10,882,188) $ 50 $ 10 $ 40 $ 1,000 $ 1,000 $ (1,273,032)
Beginning balance (in shares) at Jan. 31, 2022 1,782,073,799       50,000 10,000 40,000 1,000,000 1,000,000  
Common stock issued for preferred stock conversions $ 425,622 (199,110) 226,512
Common stock issued for preferred stock conversions (in shares) 425,622,150                
Preferred stock subscribed but not issued 50,000 50,000
Dividends on Series G preferred stock (2,429) (2,429)
Net loss (107,196)   (107,196)
Ending balance, value at Apr. 30, 2022 2,207,696 7,625,872 (10,991,813) 50,000 50 10 40 1,000 1,000 (1,106,145)
Beginning balance, value at Jan. 31, 2022 $ 1,782,074 7,824,982 (10,882,188) $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (1,273,032)
Beginning balance (in shares) at Jan. 31, 2022 1,782,073,799       50,000 10,000 40,000 1,000,000 1,000,000  
Net loss                   (286,414)
Deemed dividend on Series G convertible preferred stock                   (10,200)
Ending balance (in shares) at Oct. 31, 2022 2,300,718,171       50,000 10,000 40,000 1,000,000 1,000,000  
Ending balance, value at Oct. 31, 2022 $ 2,300,718 7,566,337 (11,182,907) 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (1,263,752)
Beginning balance, value at Apr. 30, 2022 2,207,696 7,625,872 (10,991,813) 50,000 50 10 40 1,000 1,000 (1,106,145)
Common stock issued for preferred stock conversions 93,022 (59,535) 33,487
Dividends on Series G preferred stock (1,103) (1,103)
Net loss (97,426)   (97,426)
Deemed dividend on Series G convertible preferred stock (10,200) (10,200)
Ending balance (in shares) at Jul. 31, 2022 2,207,695,949       50,000 10,000 40,000 1,000,000 1,000,000  
Ending balance, value at Jul. 31, 2022 $ 2,300,718 7,566,337 (11,100,542) 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (1,181,387)
Common stock issued for preferred stock conversions (in shares) 93,022,222                
Net loss (81,792)   (81,792)
Deemed dividend on Series G convertible preferred stock                  
Dividends on Series G convertible preferred stock (573) (573)
Ending balance (in shares) at Oct. 31, 2022 2,300,718,171       50,000 10,000 40,000 1,000,000 1,000,000  
Ending balance, value at Oct. 31, 2022 $ 2,300,718 7,566,337 (11,182,907) 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (1,263,752)
Beginning balance, value at Jan. 31, 2023 $ 2,743,575 7,889,555 (11,459,050) 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (773,820)
Beginning balance (in shares) at Jan. 31, 2023 2,743,575,314       50,000 10,000 40,000 1,000,000 1,000,000  
Common stock issued for preferred stock conversions $ 174,324 (137,715) 36,609
Common stock issued for preferred stock conversions (in shares) 174,323,810                
Net loss (71,996) (71,996)
Ending balance, value at Apr. 30, 2023 2,917,899 7,751,840 (11,531,046) 50,000 50 10 40 1,000 1,000 (809,207)
Beginning balance, value at Jan. 31, 2023 $ 2,743,575 7,889,555 (11,459,050) 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (773,820)
Beginning balance (in shares) at Jan. 31, 2023 2,743,575,314       50,000 10,000 40,000 1,000,000 1,000,000  
Net loss                   (198,829)
Deemed dividend on Series G convertible preferred stock                  
Ending balance (in shares) at Oct. 31, 2023 2,917,899,124       50,000 10,000 40,000 1,000,000 1,000,000  
Ending balance, value at Oct. 31, 2023 $ 2,917,899 7,751,840 (11,657,879) 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (936,040)
Beginning balance, value at Apr. 30, 2023 2,917,899 7,751,840 (11,531,046) 50,000 50 10 40 1,000 1,000 (809,207)
Net loss (71,847) (71,847)
Ending balance (in shares) at Jul. 31, 2023 2,917,899,124       50,000 10,000 40,000 1,000,000 1,000,000  
Ending balance, value at Jul. 31, 2023 $ 2,917,899 7,751,840 (11,602,893) 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 (881,054)
Net loss (54,986) (54,986)
Deemed dividend on Series G convertible preferred stock                  
Ending balance (in shares) at Oct. 31, 2023 2,917,899,124       50,000 10,000 40,000 1,000,000 1,000,000  
Ending balance, value at Oct. 31, 2023 $ 2,917,899 $ 7,751,840 $ (11,657,879) $ 50,000 $ 50 $ 10 $ 40 $ 1,000 $ 1,000 $ (936,040)
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) - 9 months ended Oct. 31, 2023
Series G Preferred Stock [Member]
USD ($)
shares
Beginning balance, value at Jan. 31, 2023 | $ $ 35,200
Beginning balance (in shares) at Jan. 31, 2023 | shares 35,200
Series G preferred stock converted to common stock | $ $ (35,200)
Series G Preferred Stock Converted to Common Stock | shares (35,200)
Ending balance, value at Oct. 31, 2023 | $
Ending balance (in shares) at Oct. 31, 2023 | shares
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
Oct. 31, 2023
Oct. 31, 2022
CASH FLOW FROM OPERATING ACTIVITIES:    
Net loss $ (198,829) $ (286,414)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 41,816 59,179
Changes in operating assets and liabilities    
Accounts Receivable (98)
Inventory 5,236 (26,810)
Accounts payable and accrued liabilities 21,637 (23,271)
Accounts payable to related party 116,475 76,332
Accrued interest payable 2,486 46,228
NET CASH USED IN OPERATING ACTIVITIES (11,277) (154,756)
CASH FLOWS FROM FINANCING ACTIVITIES    
Stock subscriptions received 50,000
Proceeds from sale of Series G convertible preferred stock 50,000
Proceeds from advance from related party 10,000
Proceeds from issuance of note payable 60,000
Repayments on notes payable (5,844)
NET CASH PROVIDED BY FINANCING ACTIVITIES 10,000 154,156
NET CHANGE IN CASH AND CASH EQUIVALENTS (1,277) (600)
Cash and cash equivalents at beginning of period 1,969 1,056
Cash and cash equivalents at end of period 692 456
Cash paid during the period for:    
Interest
Taxes
Noncash investing and financing transactions:    
Conversion of Series G preferred stock 36,609 250,000
Dividends on mezzanine equity 4,105
Deemed dividend on mezzanine equity 10,200
Expenses paid on the Company’s behalf $ 58,206
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Background Information
 9 Months Ended
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background Information

Note 1. Background Information

 

Neutra Corp. was incorporated in Nevada on January 11, 2011, to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. We have established a fiscal year end of January 31.

 

As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Going Concern
 9 Months Ended
Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern

Note 2. Going Concern

 

For the nine months ended October 31, 2023, the Company had a net loss of $198,829 and did not have positive cash flow from operations. As of October 31, 2023, the Company has negative working capital of $889,428. We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.

 

These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.

 

Management has plans to address the Company’s financial situation as follows:

 

In the near term, management plans to continue to focus on raising the funds necessary to implement the Company’s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raises doubts about the Company’s ability to continue as a going concern.

 

In the long term, management believes that the Company’s projects and initiatives will be successful and will provide cash flow to the Company that will be used to finance the Company’s future growth. However, there can be no assurances that the Company’s planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies
 9 Months Ended
Oct. 31, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies

Note 3. Significant Accounting Policies

 

The significant accounting policies that the Company follows are:

 

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023, and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).

 

The results of operations for the nine month period ended October 31, 2023, are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.

 

Basis of Presentation

 

The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.

 

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Inventory

 

Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of October 31, 2023, and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Property and Equipment, net

 

Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over three years beginning when the asset is put in service. For the nine months ended October 31, 2023, and 2022, the Company recognized depreciation expense of $41,816 and $59,179, respectively.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

• Identification of the contract with a customer
   
• Identification of the performance obligations in the contract
   
• Determination of the transaction price
   
• Allocation of the transaction price to the performance obligations in the contract
   
• Recognition of revenue when, or as, the Company satisfies a performance obligation

 

Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Cost of Sales

 

Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.

 

Earnings (Loss) per Common Share

 

We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.

 

Commitments and Contingencies

 

The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

 

As discussed in more detail in Note 5, the Company agreed to pay 60% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $250,000 is paid to Mr. Jim, at which point he will be entitled to 20% of revenue from Deity Corporation.

 

There were no other known commitments or contingencies as of October 31, 2023, and January 31, 2023.

 

Mezzanine equity

 

Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.

 

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

 

Recently Adopted Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Property and equipment, net
 9 Months Ended
Oct. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and equipment, net

Note 4. Property and equipment, net

 

Property and equipment consist of the following:

 

    October 31, 2023   January 31, 2023  
Equipment   $ 236,717   $ 236,717  
Total property and equipment     236,717     236,717  
Less: accumulated depreciation     (229,173 )   (187,357 )
Property and equipment, net   $ 7,544   $ 49,360  
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions
 9 Months Ended
Oct. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5. Related Party Transactions

 

During the nine months ended October 31, 2023, and 2022, we incurred salary expense of $75,000 to our CEO, Sydney Jim. In addition, we incurred commission expense of $6,879 and $26,101 during the nine months ended October 31, 2023, and 2022 to Mr. Jim and owed a total of $41,475 and $34,596 in accrued commissions as of October 31, 2023, and January 31, 2023, respectively. During the nine months ended October 31, 2023, Mr. Jim paid expenses of $41,253 on behalf of the Company.

 

As of October 31, 2023, and January 31, 2023, we owed Mr. Jim, or entities controlled by him, $407,768 and $233,087 which is recorded on the balance sheet in “Accounts Payable – Related Party”, respectively, and $12,314 and $2,314 in “Advances payable to related party”, respectively. This balance includes the commissions payable to Mr. Jim described above.

 

During the nine months ended October 31, 2023, an investor advanced $10,000 to the Company. This advance is unsecured, non-interest bearing and due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of October 31, 2023, the note principal balance was $54,156 and accrued interest was $4,322. The Company has not made all the required monthly payments under the note agreement to date.

 

During the year ended January 31, 2022, the Company acquired the assets of Deity Corporation, a Texas corporation which the Sydney Jim, the Company’s CEO, had a controlling interest in that will produce hemp and cannabis products. The transaction was considered an asset acquisition, as there were no operations of Deity Corporation prior to the transaction. The Company received the formulas for certain hemp and cannabis-based products and a website to market the products that will be produced. In exchange, the Company will pay Mr. Jim 60% of the revenue from Deity Corporation sales until a total of $250,000 is reached, at which point the Company will pay 20% of Deity Corporation revenue to Mr. Jim.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Advances and Notes Payable
 9 Months Ended
Oct. 31, 2023
Debt Disclosure [Abstract]  
Advances and Notes Payable

Note 6. Advances and Notes Payable

 

As of October 31, 2023, and January 31, 2023, we had amounts due under advances of $3,450 at each period. These advances are not collateralized, non-interest bearing and are due on demand.

 

On March 11, 2022, the Company entered into a loan agreement for $60,000 of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at 6%. The Company will make monthly payments of $4,240 per month beginning in April 2022 through the maturity at June 18, 2023. As of October 31, 2023, the note principal balance was $54,156 and accrued interest was $4,322.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders’ Equity
 9 Months Ended
Oct. 31, 2023
Equity [Abstract]  
Shareholders’ Equity

Note 7. Shareholders’ Equity

 

Series A Preferred Stock. In January 2020, our board of directors designated 50,000 shares of our preferred stock as Series A Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series A Preferred Stock has a stated value of $5 per share. The Series A Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. The holders of the Series A Preferred Stock have the option to convert each share into 800 shares of common stock of the Company. As of October 31, 2023, and January 31, 2023, there are 50,000 shares of Series A Preferred Stock outstanding.

 

Series B Preferred Stock. In July 2020, our board of directors designated 10,000 shares of our preferred stock as Series B Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series B Preferred Stock has a stated value of $5 per share. The Series B Preferred Stock is entitled to receive dividends of 0.4% of the net profit of VIVIS Corporation. Holders of the Series B Preferred Stock have the option to convert each share into 800 shares of common stock. During the year ended January 31, 2021, the Company subscribed 10,000 shares of Series B Preferred Stock for cash proceeds of $50,000. The shares were issued during the year ended January 31, 2022. As of October 31, 2023, and January 31, 2023, there are 10,000 shares of Series B Preferred Stock outstanding.

 

Series C Preferred Stock. In November 2020, our board of directors designated 40,000 shares of our preferred stock as Series C Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series C Preferred Stock has a stated value of $5 per share. The Series C Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. After the Series C Preferred Stock has received cumulative dividends of $500,000, the dividend rate will reduce to 1%. Holders of the Series C Preferred Stock have the option to convert each share into 38 shares of common stock. During the year ended January 31, 2021, the Company subscribed 40,000 shares of Series B Preferred Stock for cash proceeds of $200,000. The shares were issued during the year ended January 31, 2022. As of October 31, 2023, and January 31, 2023, there are 40,000 shares of Series C Preferred Stock outstanding.

 

Series E preferred stock issued for services

 

On November 13, 2015, our board of directors designated 1,000,000 shares of our preferred stock as Series E Preferred Stock. The Series E Preferred Stock is subordinated to our common stock. It does not receive dividends and does not participate in equity distributions. The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company. As of October 31, 2023, and January 31, 2023, there are 1,000,000 shares Series E Preferred Stock outstanding. Dividends, when, as and if declared by the Board of Directors, shall be paid out of funds at the time legally available for such purposes.

 

Series F preferred stock issued for services

 

The Series F Preferred Stock is subordinated to our common stock and superior to all shares of Preferred Stock. It does not receive dividends and does not participate in equity distributions. The Series F Preferred stock retains 2/3 of the voting rights in the company. During the year ended January 31, 2021, the Company issued 1,000,000 shares of Series F Preferred Stock to Sydney Jim, our CEO, in exchange for services. As of the date of this report, there are 1,000,000 shares Series F Preferred Stock outstanding. As of October 31, 2023, and January 31, 2023, there are 1,000,000 shares of Series F Preferred Stock outstanding.

 

Series G convertible preferred stock

 

During the nine months ended October 31, 2023, the Company the holder of the Series G convertible preferred stock converted 35,200 shares and accrued dividends of $1,408 into 174,323,810 shares of common stock. During the nine months ended October 31, 2022, the Company accrued dividends of $3,532, and the holder of the Series G convertible preferred stock converted 250,000 shares and accrued dividends of $10,000 into 518,644,372 shares of common stock. The conversions were in accordance with the terms of the agreement and no gain or loss was recognized. As of October 31, 2023, there were no shares of Series G convertible preferred stock outstanding.

 

Preferred Stock Subscription

 

On February 23, 2022, the Company sold 10,000 shares of preferred stock not yet designated for cash proceeds of $50,000.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Policies)
 9 Months Ended
Oct. 31, 2023
Accounting Policies [Abstract]  
Interim Financial Statements

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023, and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).

 

The results of operations for the nine month period ended October 31, 2023, are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.
Basis of Presentation

Basis of Presentation

 

The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.
Consolidated Financial Statements

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Inventory

Inventory

 

Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of October 31, 2023, and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, no such valuation allowance was recognized.
Property and Equipment, net

Property and Equipment, net

 

Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over three years beginning when the asset is put in service. For the nine months ended October 31, 2023, and 2022, the Company recognized depreciation expense of $41,816 and $59,179, respectively.
Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

• Identification of the contract with a customer
   
• Identification of the performance obligations in the contract
   
• Determination of the transaction price
   
• Allocation of the transaction price to the performance obligations in the contract
   
• Recognition of revenue when, or as, the Company satisfies a performance obligation

 

Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.

 

Contract Costs

 

Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.

 

Cost of Sales

 

Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.
Earnings (Loss) per Common Share

Earnings (Loss) per Common Share

 

We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.
Commitments and Contingencies

Commitments and Contingencies

 

The Company follows ASC 450-20, Loss Contingencies, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

 

As discussed in more detail in Note 5, the Company agreed to pay 60% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $250,000 is paid to Mr. Jim, at which point he will be entitled to 20% of revenue from Deity Corporation.

 

There were no other known commitments or contingencies as of October 31, 2023, and January 31, 2023.
Mezzanine equity

Mezzanine equity

 

Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.
Subsequent events

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.
Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. 
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Property and equipment, net (Tables)
 9 Months Ended
Oct. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and equipment consist of the following:

Property and equipment consist of the following:

 

    October 31, 2023   January 31, 2023  
Equipment   $ 236,717   $ 236,717  
Total property and equipment     236,717     236,717  
Less: accumulated depreciation     (229,173 )   (187,357 )
Property and equipment, net   $ 7,544   $ 49,360  
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Going Concern (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 31, 2023
Jul. 31, 2023
Apr. 30, 2023
Oct. 31, 2022
Jul. 31, 2022
Apr. 30, 2022
Oct. 31, 2023
Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]                
Net loss $ 54,986 $ 71,847 $ 71,996 $ 81,792 $ 97,426 $ 107,196 $ 198,829 $ 286,414
Working capital $ 889,428           $ 889,428  
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2023
Oct. 31, 2022
Jan. 31, 2023
Property, Plant and Equipment [Line Items]          
Valuation allowance recognized $ 0   $ 0   $ 0
Depreciation 9,051 $ 19,726 41,816 $ 59,179  
Preferred stock subscribed but not issued $ 50,000   $ 50,000   $ 50,000
Mr Jim [Member] | Chief Executive Officer [Member]          
Property, Plant and Equipment [Line Items]          
Revenue, remaining performance obligation, percentage 60.00%   60.00%    
Preferred stock subscribed but not issued $ 250,000   $ 250,000    
Deity Corporation [Member]          
Property, Plant and Equipment [Line Items]          
Revenue, remaining performance obligation, percentage 20.00%   20.00%    
Equipment [Member]          
Property, Plant and Equipment [Line Items]          
Useful life 3 years   3 years    
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Property and equipment consist of the following: (Details) - USD ($)
Oct. 31, 2023
Jan. 31, 2023
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 236,717 $ 236,717
Less: accumulated depreciation (229,173) (187,357)
Property and equipment, net 7,544 49,360
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total property and equipment $ 236,717 $ 236,717
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions (Details Narrative) - USD ($)
 9 Months Ended 12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Jan. 31, 2023
Mar. 11, 2022
Jan. 31, 2022
Related Party Transaction [Line Items]          
Expenses paid $ 58,206      
Advances payable to related party 12,314   $ 2,314    
Investor advance 10,000      
Loan agreement       $ 60,000  
Unsecured loan interest       6.00%  
Monthly interest payment       $ 4,240  
Principal balance 54,156        
Accrued interest 4,322        
Chief Executive Officer [Member]          
Related Party Transaction [Line Items]          
Salary expense 75,000 75,000      
Commission expense 6,879 $ 26,101      
Accrued commission 41,475   34,596    
Chief Executive Officer [Member] | Accounts Payable Related Party and Advances Payable to Related Party [Member]          
Related Party Transaction [Line Items]          
Accounts payable - related party 407,768   233,087    
Advances payable to related party 12,314   $ 2,314    
Chief Executive Officer [Member] | Mr Jim [Member]          
Related Party Transaction [Line Items]          
Expenses paid $ 41,253        
Revenue obligation from Deity Corporation before sales threshold, percentage         60.00%
Revenue obligation from Deity Corporation sales threshold         $ 250,000
Revenue obligation from Deity Corporation after sales threshold, percentage         20.00%
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Advances and Notes Payable (Details Narrative) - USD ($)
 9 Months Ended
Oct. 31, 2023
Jan. 31, 2023
Mar. 11, 2022
Debt Disclosure [Abstract]      
Advances payable $ 3,450 $ 3,450  
Loan agreement     $ 60,000
Unsecured loan intrest     6.00%
Monthly intrest payment     $ 4,240
Loan agreement 54,156    
Accrued interest $ 4,322    
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Feb. 23, 2022
Nov. 13, 2015
Nov. 30, 2020
Jul. 31, 2020
Jan. 31, 2020
Oct. 31, 2023
Jan. 31, 2021
Jan. 31, 2023
Oct. 31, 2022
Class of Stock [Line Items]                  
Preferred stock, par value (in dollars per share)           $ 0.001   $ 0.001  
Number of shares sold 10,000                
Cash proceeds $ 50,000                
Series A Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued         50,000 50,000   50,000  
Preferred stock, par value (in dollars per share)         $ 5        
Prefered stock converted into common stock         800        
Preferred stock, outstanding           50,000   50,000  
Series A Preferred Stock [Member] | VIVIS Corporation [Member]                  
Class of Stock [Line Items]                  
Preferred stock, dividend rate, percentage         10.00%        
Series B Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued       10,000   10,000   0  
Preferred stock, par value (in dollars per share)       $ 5          
Prefered stock converted into common stock       800          
Preferred stock, outstanding           10,000   0  
Number of shares sold             10,000    
Cash proceeds             $ 50,000    
Shares outstanding           10,000   10,000  
Series B Preferred Stock [Member] | VIVIS Corporation [Member]                  
Class of Stock [Line Items]                  
Preferred stock, dividend rate, percentage       0.40%          
Series C Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued     40,000     40,000   40,000  
Preferred stock, par value (in dollars per share)     $ 5            
Preferred stock, dividend rate, percentage     1.00%            
Prefered stock converted into common stock     38            
Preferred stock, outstanding           40,000   40,000  
Number of shares sold             40,000    
Cash proceeds             $ 200,000    
Shares outstanding           40,000   40,000  
Series C Preferred Stock [Member] | VIVIS Corporation [Member]                  
Class of Stock [Line Items]                  
Preferred stock, dividend rate, percentage     10.00%            
Convertible Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Cumulative dividends received     $ 500,000            
Series E Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued   1,000,000       1,000,000   1,000,000  
Preferred stock, outstanding           1,000,000   1,000,000  
Description of voting rights   The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company.              
Series F Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued           1,000,000   1,000,000  
Preferred stock, par value (in dollars per share)           $ 0.001   $ 0.001  
Preferred stock, outstanding           1,000,000 1,000,000 1,000,000  
Description of voting rights           The Series F Preferred stock retains 2/3 of the voting rights in the company.      
Series F Preferred Stock [Member] | Chief Executive Officer [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued             1,000,000    
Series G Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Preferred stock, issued           0   35,200  
Preferred stock, par value (in dollars per share)           $ 1.00   $ 1.00  
Prefered stock converted into common stock           174,323,810     518,644,372
Preferred stock, outstanding           0   35,200  
Prefered stock converted into common stock           35,200     250,000
Accrured dividends           $ 1,408     $ 10,000
Dividends payable                 $ 3,532
XML 32 form_10-q_htm.xml IDEA: XBRL DOCUMENT 0001512886 2023-02-01 2023-10-31 0001512886 2023-12-15 0001512886 2023-10-31 0001512886 2023-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-10-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-01-31 0001512886 2022-02-01 2023-01-31 0001512886 2023-08-01 2023-10-31 0001512886 2022-08-01 2022-10-31 0001512886 2022-02-01 2022-10-31 0001512886 us-gaap:CommonStockMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0001512886 us-gaap:RetainedEarningsMember 2022-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-01-31 0001512886 2022-01-31 0001512886 us-gaap:CommonStockMember 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-04-30 0001512886 2022-04-30 0001512886 us-gaap:CommonStockMember 2022-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001512886 us-gaap:RetainedEarningsMember 2022-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-07-31 0001512886 2022-07-31 0001512886 us-gaap:CommonStockMember 2023-01-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001512886 us-gaap:RetainedEarningsMember 2023-01-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-01-31 0001512886 us-gaap:CommonStockMember 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-04-30 0001512886 2023-04-30 0001512886 us-gaap:CommonStockMember 2023-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001512886 us-gaap:RetainedEarningsMember 2023-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-07-31 0001512886 2023-07-31 0001512886 us-gaap:CommonStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2022-02-01 2022-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-02-01 2022-04-30 0001512886 us-gaap:RetainedEarningsMember 2022-02-01 2022-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-02-01 2022-04-30 0001512886 2022-02-01 2022-04-30 0001512886 us-gaap:CommonStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-05-01 2022-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-07-31 0001512886 us-gaap:RetainedEarningsMember 2022-05-01 2022-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-05-01 2022-07-31 0001512886 2022-05-01 2022-07-31 0001512886 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-08-01 2022-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001512886 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-08-01 2022-10-31 0001512886 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesAPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesBPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesCPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesEPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:SeriesFPreferredStockMember 2023-02-01 2023-04-30 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001512886 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-02-01 2023-04-30 0001512886 2023-02-01 2023-04-30 0001512886 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-05-01 2023-07-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001512886 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-05-01 2023-07-31 0001512886 2023-05-01 2023-07-31 0001512886 us-gaap:CommonStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2023-08-01 2023-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-08-01 2023-10-31 0001512886 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-08-01 2023-10-31 0001512886 us-gaap:CommonStockMember 2022-10-31 0001512886 us-gaap:SeriesAPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesBPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesCPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesEPreferredStockMember 2022-10-31 0001512886 us-gaap:SeriesFPreferredStockMember 2022-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001512886 us-gaap:RetainedEarningsMember 2022-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2022-10-31 0001512886 2022-10-31 0001512886 us-gaap:CommonStockMember 2023-10-31 0001512886 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001512886 us-gaap:RetainedEarningsMember 2023-10-31 0001512886 ntrr:StockSubscribedButNotIssuedMember 2023-10-31 0001512886 us-gaap:SeriesGPreferredStockMember 2023-02-01 2023-10-31 0001512886 us-gaap:EquipmentMember 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2023-10-31 0001512886 ntrr:DeityCorporationMember 2023-10-31 0001512886 us-gaap:EquipmentMember 2023-01-31 0001512886 srt:ChiefExecutiveOfficerMember 2023-02-01 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember 2022-02-01 2022-10-31 0001512886 srt:ChiefExecutiveOfficerMember 2022-02-01 2023-01-31 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2023-02-01 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember ntrr:AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember 2023-01-31 0001512886 2022-03-11 0001512886 srt:ChiefExecutiveOfficerMember ntrr:MrJimMember 2022-01-31 0001512886 us-gaap:SeriesAPreferredStockMember 2020-01-31 0001512886 ntrr:VIVISCorporationMember us-gaap:SeriesAPreferredStockMember 2020-01-01 2020-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-07-31 0001512886 ntrr:VIVISCorporationMember us-gaap:SeriesBPreferredStockMember 2020-07-01 2020-07-31 0001512886 us-gaap:SeriesBPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesBPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-30 0001512886 ntrr:VIVISCorporationMember us-gaap:SeriesCPreferredStockMember 2020-11-01 2020-11-30 0001512886 us-gaap:ConvertiblePreferredStockMember 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2020-11-01 2020-11-30 0001512886 us-gaap:SeriesCPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesCPreferredStockMember 2020-02-01 2021-01-31 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-13 0001512886 us-gaap:SeriesEPreferredStockMember 2015-11-12 2015-11-13 0001512886 us-gaap:SeriesFPreferredStockMember 2023-02-01 2023-10-31 0001512886 srt:ChiefExecutiveOfficerMember us-gaap:SeriesFPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesFPreferredStockMember 2021-01-31 0001512886 us-gaap:SeriesGPreferredStockMember 2022-10-31 0001512886 2022-02-23 0001512886 2022-02-21 2022-02-23 iso4217:USD shares iso4217:USD shares pure false 2024 Q3 --01-31 0001512886 Unlimited Unlimited P3Y 10-Q true 2023-10-31 false 0-55077 NEUTRA CORP. WY 27-4505461 54 Sugar Creek Center Blvd. Suite 200 Sugar Land TX 77478 702 793-4121 Yes Yes Non-accelerated Filer true false false 2917899124 692 1969 98 18610 23846 19400 25815 7544 49360 26944 75175 480974 516890 407768 233087 3450 3450 12314 2314 2062 4322 1836 908828 759639 54156 54156 962984 813795 1.00 1.00 0 0 35200 35200 35200 0.001 0.001 2917899124 2917899124 2743575314 2743575314 2917899 2743575 0.001 0.001 20000000 20000000 50000 50000 50000 50000 50 50 10000 10000 0 0 10 10 40000 40000 40000 40000 40 40 1000000 1000000 1000000 1000000 1000 1000 0.001 0.001 1000000 1000000 1000000 1000000 1000 1000 7751840 7889555 50000 50000 -11657879 -11459050 -936040 -773820 26944 75175 1311 23383 11478 62077 722 12708 6403 29725 589 10675 5075 32352 9051 19726 41816 59179 779 10584 6879 26101 43487 46439 152085 186958 -53317 -76749 -200780 -272238 -52728 -66074 -195705 -239886 2258 15718 2486 46528 -2258 -15718 -2486 -46528 -54986 -81792 -198191 -286414 638 -54986 -81792 -198829 -286414 573 4105 -10200 -54986 -82365 -198829 -300719 -0.00 -0.00 -0.00 -0.00 2917899124 2300718171 2914202623 2187836449 1782073799 1782074 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7824982 -10882188 -1273032 425622150 425622 -199110 226512 50000 50000 -2429 -2429 -107196 -107196 2207695949 2207696 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7625872 -10991813 50000 -1106145 93022222 93022 -59535 33487 -1103 -1103 -10200 -10200 -97426 -97426 2300718171 2300718 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7566337 -11100542 50000 -1181387 -573 -573 -81792 -81792 2300718171 2300718 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7566337 -11182907 50000 -1263752 2743575314 2743575 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7889555 -11459050 50000 -773820 174323810 174324 -137715 36609 -71996 -71996 2917899124 2917899 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7751840 -11531046 50000 -809207 -71847 -71847 2917899124 2917899 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7751840 -11602893 50000 -881054 -54986 -54986 2917899124 2917899 50000 50 10000 10 40000 40 1000000 1000 1000000 1000 7751840 -11657879 50000 -936040 35200 35200 -35200 -35200 -198829 -286414 41816 59179 98 -5236 26810 21637 -23271 116475 76332 2486 46228 -11277 -154756 50000 50000 10000 60000 5844 10000 154156 -1277 -600 1969 1056 692 456 36609 250000 4105 10200 58206 <p id="xdx_80E_eus-gaap--NatureOfOperations_z2fhThb8dNH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1. <span id="xdx_82C_z6kgBNGG0Zz9">Background Information</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Neutra Corp. was incorporated in Nevada on January 11, 2011, to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. We have established a fiscal year end of January 31.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.</p> <p id="xdx_804_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zFRg0l4Gp4ti" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2. <span id="xdx_82F_zoikPxA08pL5">Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the nine months ended October 31, 2023, the Company had a net loss of $<span id="xdx_90B_eus-gaap--NetIncomeLoss_iN_di_c20230201__20231031_zQM3GGVBD1xf" title="Net loss">198,829</span> and did not have positive cash flow from operations. As of October 31, 2023, the Company has negative working capital of $<span id="xdx_902_ecustom--WorkingCapital_iI_c20231031_z1DiCOfOFIS5" title="Working capital">889,428</span>. We have generated limited revenues to date and our activities have been primarily limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management has plans to address the Company’s financial situation as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the near term, management plans to continue to focus on raising the funds necessary to implement the Company’s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raises doubts about the Company’s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the long term, management believes that the Company’s projects and initiatives will be successful and will provide cash flow to the Company that will be used to finance the Company’s future growth. However, there can be no assurances that the Company’s planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.</p> -198829 889428 <p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_zdecGelu9dE4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3. <span id="xdx_829_zxu4tagxnT0i">Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The significant accounting policies that the Company follows are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_ecustom--InterimFinancialStatementsPolicyTextBlock_zPO9cCb6cXOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_86E_z3zRFY4r2HG6">Interim Financial Statements</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023, and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The results of operations for the nine month period ended October 31, 2023, are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.</p> <p id="xdx_856_zTa2r3RPfByl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVF7v4gS40h4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zxCE8h2igZEi">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.</p> <p id="xdx_855_zK3UkClngVmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zpokeaGN3Y94" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zto0kZF4IBvl">Consolidated Financial Statements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.</p> <p id="xdx_85B_zc7ppX5yqgp" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--UseOfEstimates_zL1euv0qvpu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zLs3E0R61NSl">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p id="xdx_85A_z1KuwurNhUC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--InventoryFinishedGoodsPolicy_zm2kto8PPwje" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zhkmChkfmMwd">Inventory</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of October 31, 2023, and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, <span id="xdx_909_eus-gaap--InventoryValuationReserves_iI_do_c20231031_zNyT83u8pvG1" title="Valuation allowance recognized"><span id="xdx_904_eus-gaap--InventoryValuationReserves_iI_do_c20230131_zVkkY9ka7pP9" title="Valuation allowance recognized">no</span></span> such valuation allowance was recognized.</p> <p id="xdx_852_zEgwS6pFevYe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zJM2qUEOT7i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zZMMhpaGKgQk">Property and Equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zRIxlG4Fxwr4" title="Useful life::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0766">three</span></span> years beginning when the asset is put in service. For the nine months ended October 31, 2023, and 2022, the Company recognized depreciation expense of $<span id="xdx_901_eus-gaap--DepreciationAndAmortization_c20230201__20231031_z905W2HO9pz3" title="Depreciation">41,816</span> and $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_c20220201__20221031_zII5Vcndf4Y2" title="Depreciation">59,179</span>, respectively.</p> <p id="xdx_852_zEpSXk9bRhq9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zq5O24YltdCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_z6mac3RZhcpj">Revenue Recognition</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 7.5in; background-color: white; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in; text-align: center">•</td> <td style="width: 7in">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Contract Costs</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cost of Sales</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.</p> <p id="xdx_858_zK0dborNCZWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zvzBRUBuxNLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zP5qT6SP6ina">Earnings (Loss) per Common Share</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, <i>Earnings per Share</i>. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.</p> <p id="xdx_859_zt3A6ZeMS3Aj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlFUXdyAmEf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zuAPmyWi5Cx">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows ASC 450-20, <i>Loss Contingencies</i>, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in more detail in Note 5, the Company agreed to pay <span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zfXNMLXIIyXc" title="Revenue, remaining performance obligation, percentage">60</span>% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $<span id="xdx_908_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_pid_uUSD_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQvTGMwSwOPb" title="Preferred stock subscribed but not issued">250,000</span> is paid to Mr. Jim, at which point he will be entitled to <span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DeityCorporationMember_zlHTYmvzC4oh" title="Revenue, remaining performance obligation, percentage">20</span>% of revenue from Deity Corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no other known commitments or contingencies as of October 31, 2023, and January 31, 2023.</p> <p id="xdx_85D_zneeMcwX9kei" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_844_ecustom--MezzanineEquityPolicyTextBlock_zLyutGnDSV78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zjoFj5f1LE79">Mezzanine equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.</p> <p id="xdx_85E_zQxFh0elzGu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zRPmkL3nH0Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="xdx_860_zZISvwwsrFd">Subsequent events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</span></p> <p id="xdx_854_zVx5vNdjKknj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zdcxJjFBLs75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zwHcfpSVpk99">Recently Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. </p> <p id="xdx_85B_zHNulXqVJxni" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p id="xdx_842_ecustom--InterimFinancialStatementsPolicyTextBlock_zPO9cCb6cXOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span><span id="xdx_86E_z3zRFY4r2HG6">Interim Financial Statements</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2023, and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The results of operations for the nine month period ended October 31, 2023, are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2024.</p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVF7v4gS40h4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zxCE8h2igZEi">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC. The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with GAAP.</p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_zpokeaGN3Y94" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_863_zto0kZF4IBvl">Consolidated Financial Statements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, Diamond Anvil Designs, LLC Deity Corporation and Vivis Corporation (Vivis), from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.</p> <p id="xdx_840_eus-gaap--UseOfEstimates_zL1euv0qvpu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zLs3E0R61NSl">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p id="xdx_84D_eus-gaap--InventoryFinishedGoodsPolicy_zm2kto8PPwje" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zhkmChkfmMwd">Inventory</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is comprised of packaging and supplies and at times raw materials. Inventory is valued at cost, based on the average cost method, unless and until the net realizable value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to the net realizable value. As of October 31, 2023, and January 31, 2023, market values of all of our inventory were greater than cost, and accordingly, <span id="xdx_909_eus-gaap--InventoryValuationReserves_iI_do_c20231031_zNyT83u8pvG1" title="Valuation allowance recognized"><span id="xdx_904_eus-gaap--InventoryValuationReserves_iI_do_c20230131_zVkkY9ka7pP9" title="Valuation allowance recognized">no</span></span> such valuation allowance was recognized.</p> 0 0 <p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zJM2qUEOT7i5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zZMMhpaGKgQk">Property and Equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment consist of equipment used to manufacture the Company’s products and is presented at cost. Depreciation is recognized over the useful life of the equipment on a straight-line basis over <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zRIxlG4Fxwr4" title="Useful life::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0766">three</span></span> years beginning when the asset is put in service. For the nine months ended October 31, 2023, and 2022, the Company recognized depreciation expense of $<span id="xdx_901_eus-gaap--DepreciationAndAmortization_c20230201__20231031_z905W2HO9pz3" title="Depreciation">41,816</span> and $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_c20220201__20221031_zII5Vcndf4Y2" title="Depreciation">59,179</span>, respectively.</p> 41816 59179 <p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zq5O24YltdCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_z6mac3RZhcpj">Revenue Recognition</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company recognizes revenue in accordance with ASC Topic 606, Revenue From Contracts With Customers. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 7.5in; background-color: white; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in; text-align: center">•</td> <td style="width: 7in">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: top"> <td style="text-align: center">•</td> <td>Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Product sales are recognized all of the following criteria are satisfied: (i) a contract with an end user exists which has commercial substance; (ii) it is probable the Company will collect the amount charged to the end user; and (iii) the Company has completed its performance obligation whereby the end user has obtained control of the product. A contract with commercial substance exists once the Company receives and accepts a purchase order or once it enters into a contract with an end user. If collectability is not probable, the sale is deferred and not recognized until collection is probable or payment is received. Control of products typically transfers when title and risk of ownership of the product has transferred to the customer. Payment is received before shipment of the product. Net revenues comprise gross revenues less customer discounts and allowances, actual and expected returns. Shipping charges billed to customers are included in net sales. Various taxes on the sale of products to customers are collected by the Company as an agent and remitted to the respective taxing authority. These taxes are presented on a net basis and recorded as a liability until remitted to the respective taxing authority. The Company allows for customers to return unopened products within 10 days in certain limited circumstances. There have been no refunds processed for returned product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Contract Costs</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred to obtain a customer contract are not material to the Company. The Company elected to apply the practical expedient to not capitalize contract costs to obtain contracts with a duration of one year or less, which are expensed and included within cost of goods and services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cost of Sales</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes all of the costs to purchase and assemble the Company’s products. Products are manufactured for the Company by third-party contractors, such costs represent the amounts invoiced by the contractors. Additionally, shipping costs are included in Cost of Sales in the Statements of Operations.</p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zvzBRUBuxNLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86E_zP5qT6SP6ina">Earnings (Loss) per Common Share</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, <i>Earnings per Share</i>. The basic earnings (loss) per common share are calculated by dividing our net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing our net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.</p> <p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zlFUXdyAmEf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zuAPmyWi5Cx">Commitments and Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows ASC 450-20, <i>Loss Contingencies</i>, to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in more detail in Note 5, the Company agreed to pay <span id="xdx_90B_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zfXNMLXIIyXc" title="Revenue, remaining performance obligation, percentage">60</span>% of all revenue from Deity Corporation to Sydney Jim, the Company’s CEO, up until a total of $<span id="xdx_908_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_pid_uUSD_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zQvTGMwSwOPb" title="Preferred stock subscribed but not issued">250,000</span> is paid to Mr. Jim, at which point he will be entitled to <span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DeityCorporationMember_zlHTYmvzC4oh" title="Revenue, remaining performance obligation, percentage">20</span>% of revenue from Deity Corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no other known commitments or contingencies as of October 31, 2023, and January 31, 2023.</p> 0.60 250000 0.20 <p id="xdx_844_ecustom--MezzanineEquityPolicyTextBlock_zLyutGnDSV78" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_864_zjoFj5f1LE79">Mezzanine equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Where ordinary or preferred shares are determined to be conditionally redeemable upon the occurrence of certain events that are not solely within the control of the issuer, and upon such event, the shares would become redeemable at the option of the holders, they are classified as ‘mezzanine equity’ (temporary equity). The purpose of this classification is to convey that such a security may not be permanently part of equity and could result in a demand for cash, securities or other assets of the entity in the future.</p> <p id="xdx_848_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zRPmkL3nH0Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="xdx_860_zZISvwwsrFd">Subsequent events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</span></p> <p id="xdx_849_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zdcxJjFBLs75" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zwHcfpSVpk99">Recently Adopted Accounting Pronouncements</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements. </p> <p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zyTYGpidjuUf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4. <span id="xdx_827_zRLWbab7umEi">Property and equipment, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zn4983C7pYE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B3_z2jxgG4W4wQj">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 4.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>October 31, 2023</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>January 31, 2023</b></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td style="width: 139.05pt">Equipment</td> <td style="width: 0.1in"> </td> <td style="width: 7.7pt">$</td> <td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zPKmtuy3SYf7" style="width: 72.35pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.2in"> </td> <td style="width: 8pt">$</td> <td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zxtG1FESaQHi" style="width: 72.05pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.1in"> </td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Total property and equipment</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231031_zgdrEDhed2zi" style="border-top: black 1pt solid; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131_zdciMNnximg3" style="border-top: black 1pt solid; background-color: white; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td>Less: accumulated depreciation</td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20231031_z4ZlS67k2RW4" style="text-align: right" title="Less: accumulated depreciation">(229,173</td> <td>)</td> <td> </td> <td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230131_zVgevYvQCpEh" style="text-align: right" title="Less: accumulated depreciation">(187,357</td> <td>)</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Property and equipment, net</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20231031_zbrnoefapja2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Property and equipment, net">7,544</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20230131_zjUAJRPlRCcc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white; text-align: right" title="Property and equipment, net">49,360</td> <td style="background-color: white"> </td></tr> </table> <p id="xdx_8A6_z5EvNZLH3Byd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zn4983C7pYE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B3_z2jxgG4W4wQj">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 4.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>October 31, 2023</b></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>January 31, 2023</b></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td style="width: 139.05pt">Equipment</td> <td style="width: 0.1in"> </td> <td style="width: 7.7pt">$</td> <td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231031__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zPKmtuy3SYf7" style="width: 72.35pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.2in"> </td> <td style="width: 8pt">$</td> <td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zxtG1FESaQHi" style="width: 72.05pt; text-align: right" title="Equipment">236,717</td> <td style="width: 0.1in"> </td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Total property and equipment</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20231031_zgdrEDhed2zi" style="border-top: black 1pt solid; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; background-color: white"> </td> <td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230131_zdciMNnximg3" style="border-top: black 1pt solid; background-color: white; text-align: right" title="Total property and equipment">236,717</td> <td style="background-color: white"> </td></tr> <tr style="vertical-align: bottom; background-color: #E1FFFF"> <td>Less: accumulated depreciation</td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20231031_z4ZlS67k2RW4" style="text-align: right" title="Less: accumulated depreciation">(229,173</td> <td>)</td> <td> </td> <td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230131_zVgevYvQCpEh" style="text-align: right" title="Less: accumulated depreciation">(187,357</td> <td>)</td></tr> <tr style="vertical-align: bottom"> <td style="background-color: white">Property and equipment, net</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20231031_zbrnoefapja2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right" title="Property and equipment, net">7,544</td> <td style="background-color: white"> </td> <td style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white">$</td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20230131_zjUAJRPlRCcc" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; background-color: white; text-align: right" title="Property and equipment, net">49,360</td> <td style="background-color: white"> </td></tr> </table> 236717 236717 236717 236717 229173 187357 7544 49360 <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zGi7Q3ZocNyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5. <span id="xdx_82A_zTcWrl6Mqck6">Related Party Transactions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended October 31, 2023, and 2022, we incurred salary expense of $<span id="xdx_903_eus-gaap--SalariesAndWages_c20230201__20231031__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zbGYdenY1bw3" title="Salary expense"><span id="xdx_907_eus-gaap--SalariesAndWages_c20220201__20221031__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zqbrNxBFQ9Ph" title="Salary expense">75,000</span></span> to our CEO, Sydney Jim. In addition, we incurred commission expense of $<span id="xdx_906_eus-gaap--CostsAndExpensesRelatedParty_c20230201__20231031__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z98N1d98yBK1" title="Commission expense">6,879</span> and $<span id="xdx_901_eus-gaap--CostsAndExpensesRelatedParty_c20220201__20221031__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zVBkVGM6VTTj" title="Commission expense">26,101</span> during the nine months ended October 31, 2023, and 2022 to Mr. Jim and owed a total of $<span id="xdx_904_ecustom--UnpaidCompensation_c20230201__20231031__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zT4Qhp2hyQFg" title="Accrued commission">41,475</span> and $<span id="xdx_90F_ecustom--UnpaidCompensation_c20220201__20230131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zPTdyQewZm5b" title="Accrued commission">34,596</span> in accrued commissions as of October 31, 2023, and January 31, 2023, respectively. During the nine months ended October 31, 2023, Mr. Jim paid expenses of $<span id="xdx_90E_ecustom--ExpensesPaidOnCompanysBehalf_c20230201__20231031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z3SFVjVb2JZ6" title="Expenses paid">41,253</span> on behalf of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of October 31, 2023, and January 31, 2023, we owed Mr. Jim, or entities controlled by him, $<span id="xdx_90A_ecustom--OtherLiabilityCurrentRelatedParty_iI_c20231031__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_znMX5mM6S8oa" title="Accounts payable - related party">407,768</span> and $<span id="xdx_90F_ecustom--OtherLiabilityCurrentRelatedParty_iI_c20230131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_zrFRPrztnl9f" title="Accounts payable - related party">233,087</span> which is recorded on the balance sheet in “Accounts Payable – Related Party”, respectively, and $<span id="xdx_900_ecustom--AdvancesPayableToRelatedParty_iI_c20231031__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_zBz3mnQ14nmh" title="Advances payable to related party">12,314</span> and $<span id="xdx_90B_ecustom--AdvancesPayableToRelatedParty_iI_c20230131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--BalanceSheetLocationAxis__custom--AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember_z3cd2LcCF7Ka" title="Advances payable to related party">2,314</span> in “Advances payable to related party”, respectively. This balance includes the commissions payable to Mr. Jim described above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended October 31, 2023, an investor advanced $<span id="xdx_90B_ecustom--ProceedsFromAdvanceFromRelatedParty_c20230201__20231031_zdEpx3r4Qlv1" title="Investor advance">10,000</span> to the Company. This advance is unsecured, non-interest bearing and due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 11, 2022, the Company entered into a loan agreement for $<span id="xdx_906_ecustom--LoanAgreement_iI_c20220311_zDdkw4OB8zw3" title="Loan agreement">60,000</span> of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at <span id="xdx_907_ecustom--UnsecuredLoanIntrest_iI_pid_dp_uPure_c20220311_zCzs4OUdQ63k" title="Unsecured loan interest">6</span>%. The Company will make monthly payments of $<span id="xdx_909_ecustom--MonthlyInterestPayment_iI_c20220311_zQn3umoMaUpl" title="Monthly interest payment">4,240</span> per month beginning in April 2022 through the maturity at June 18, 2023. As of October 31, 2023, the note principal balance was $<span id="xdx_90C_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20231031_zFcEDm6P72P6" title="Principal balance">54,156</span> and accrued interest was $<span id="xdx_90F_ecustom--FinancingReceivableAccruedInterest_c20230201__20231031_z1Le0LwYxHr9" title="Accrued interest">4,322</span>. The Company has not made all the required monthly payments under the note agreement to date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended January 31, 2022, the Company acquired the assets of Deity Corporation, a Texas corporation which the Sydney Jim, the Company’s CEO, had a controlling interest in that will produce hemp and cannabis products. The transaction was considered an asset acquisition, as there were no operations of Deity Corporation prior to the transaction. The Company received the formulas for certain hemp and cannabis-based products and a website to market the products that will be produced. In exchange, the Company will pay Mr. Jim <span id="xdx_904_ecustom--RevenueObligationBeforePercentage_iI_pid_dp_uPure_c20220131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember_z2vnmEm4L4q5" title="Revenue obligation from Deity Corporation before sales threshold, percentage">60</span>% of the revenue from Deity Corporation sales until a total of $<span id="xdx_90E_ecustom--RevenueObligationThreshold_iI_c20220131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember_zudufiWOY4ib" title="Revenue obligation from Deity Corporation sales threshold">250,000</span> is reached, at which point the Company will pay <span id="xdx_908_ecustom--RevenueObligationAfterPercentage_iI_pid_dp_uPure_c20220131__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJimMember_zwRjmJ4KQ91k" title="Revenue obligation from Deity Corporation after sales threshold, percentage">20</span>% of Deity Corporation revenue to Mr. Jim.</p> 75000 75000 6879 26101 41475 34596 41253 407768 233087 12314 2314 10000 60000 0.06 4240 54156 4322 0.60 250000 0.20 <p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zif8an9ngyX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6. <span id="xdx_82E_zaaUcCLGhixb">Advances and Notes Payable</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of October 31, 2023, and January 31, 2023, we had amounts due under advances of $<span id="xdx_904_ecustom--AdvancesPayable_iI_c20231031_zGRu5bInuR44" title="Advances payable"><span id="xdx_90F_ecustom--AdvancesPayable_iI_c20230131_zKSmKLe6CK6a" title="Advances payable">3,450</span></span> at each period. These advances are not collateralized, non-interest bearing and are due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 11, 2022, the Company entered into a loan agreement for $<span id="xdx_90D_ecustom--LoanAgreement_iI_c20220311_zrFcRgVZYOn2" title="Loan agreement">60,000</span> of proceeds with the holder of the Company’s Series A and B preferred stock. The loan is unsecured and bears interest at <span id="xdx_908_ecustom--UnsecuredLoanIntrest_iI_dp_c20220311_zBs8T6QoMhO1" title="Unsecured loan intrest">6</span>%. The Company will make monthly payments of $<span id="xdx_90A_ecustom--MonthlyIntrestPayment_iI_c20220311_zsxR9pUsKBpa" title="Monthly intrest payment">4,240</span> per month beginning in April 2022 through the maturity at June 18, 2023. As of October 31, 2023, the note principal balance was $<span id="xdx_90C_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_c20231031_zJArTBGOl9Bj" title="Loan agreement">54,156</span> and accrued interest was $<span id="xdx_903_eus-gaap--FinancingReceivableAccruedInterestWriteoff_c20230201__20231031_zeFkG6sPSxMi" title="Accrued interest">4,322</span>.</p> 3450 3450 60000 0.06 4240 54156 4322 <p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zgWLaeJyfbek" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7. <span id="xdx_828_zsmbNdCFBbqc">Shareholders’ Equity</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series A Preferred Stock.</i></b> In January 2020, our board of directors designated <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zU6fCwdGxefd" title="Preferred stock, issued">50,000</span> shares of our preferred stock as Series A Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series A Preferred Stock has a stated value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zD3CIn1T3rdg" title="Preferred stock, par value (in dollars per share)">5</span> per share. The Series A Preferred Stock is entitled to receive dividends of <span id="xdx_90A_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20200101__20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--ConsolidatedEntitiesAxis__custom--VIVISCorporationMember_zD0Ft1A8dryj" title="Preferred stock, dividend rate, percentage">10</span>% of the net profit of VIVIS Corporation. The holders of the Series A Preferred Stock have the option to convert each share into <span id="xdx_900_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20200131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zIoLv9PX28i9" title="Prefered stock converted into common stock">800</span> shares of common stock of the Company. As of October 31, 2023, and January 31, 2023, there are <span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zupvLShdefEh" title="Preferred stock, outstanding"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zjkFjOqZFS1f" title="Preferred stock, outstanding">50,000</span></span> shares of Series A Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series B Preferred Stock.</i></b> In July 2020, our board of directors designated <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_ziVVerFCabV6">10,000</span> shares of our preferred stock as Series B Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series B Preferred Stock has a stated value of $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zwOuwoEeMZhf">5</span> per share. The Series B Preferred Stock is entitled to receive dividends of <span id="xdx_908_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20200701__20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--ConsolidatedEntitiesAxis__custom--VIVISCorporationMember_z0i9SwSKcVK8">0.4</span>% of the net profit of VIVIS Corporation. Holders of the Series B Preferred Stock have the option to convert each share into <span id="xdx_90F_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20200731__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zzBTbEhgnPo8">800</span> shares of common stock. During the year ended January 31, 2021, the Company subscribed <span id="xdx_904_eus-gaap--PreferredStockShareSubscriptions_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zKCAvV8M2Wud" title="Subscription of stock">10,000</span> shares of Series B Preferred Stock for cash proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromRepaymentsOfDebt_c20200201__20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zpGh5nyWVhm4" title="Cash proceeds">50,000</span>. The shares were issued during the year ended January 31, 2022. As of October 31, 2023, and January 31, 2023, there are <span id="xdx_907_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEBx52LktQuj" title="Shares outstanding"><span id="xdx_90B_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEN35sH6Lj4l" title="Shares outstanding">10,000</span></span> shares of Series B Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series C Preferred Stock.</i></b> In November 2020, our board of directors designated <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zFsK7Jdel6Q1">40,000</span> shares of our preferred stock as Series C Preferred Stock which rank subordinate to all shares of common stock and do not have voting rights. The Series C Preferred Stock has a stated value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zri2ccMS7bvj">5</span> per share. The Series C Preferred Stock is entitled to receive dividends of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20201101__20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__srt--ConsolidatedEntitiesAxis__custom--VIVISCorporationMember_zpkwzsAjjjic">10</span>% of the net profit of VIVIS Corporation. After the Series C Preferred Stock has received cumulative dividends of $<span id="xdx_908_eus-gaap--CumulativeDividends_iI_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zkNqKbRzdyBe" title="Cumulative dividends received">500,000</span>, the dividend rate will reduce to <span id="xdx_90B_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20201101__20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zPSJnAVNJt2a">1</span>%. Holders of the Series C Preferred Stock have the option to convert each share into <span id="xdx_90C_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20201130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zM4mrEEAH4Kl">38</span> shares of common stock. During the year ended January 31, 2021, the Company subscribed <span id="xdx_90E_eus-gaap--PreferredStockShareSubscriptions_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_za7LxABz6ig8" title="Shares subscriptions">40,000</span> shares of Series B Preferred Stock for cash proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromRepaymentsOfDebt_c20200201__20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zHhAo0MQDSlb">200,000</span>. The shares were issued during the year ended January 31, 2022. As of October 31, 2023, and January 31, 2023, there are <span id="xdx_90E_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zxSOVZQQG4Xi"><span id="xdx_90F_ecustom--PreferredStockSharesOutstanding1_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zrXmDVBuTe24">40,000</span></span> shares of Series C Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series E preferred stock issued for services</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 13, 2015, our board of directors designated <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20151113__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zBtht5OIrMyg">1,000,000</span> shares of our preferred stock as Series E Preferred Stock. The Series E Preferred Stock is subordinated to our common stock. It does not receive dividends and does not participate in equity distributions. <span id="xdx_909_eus-gaap--PreferredStockVotingRights_c20151112__20151113__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z6MnKjFlAFg1" title="Description of voting rights">The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company.</span> As of October 31, 2023, and January 31, 2023, there are <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zEMd5SuuO1jc"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z4f2esfGJOP3">1,000,000</span></span> shares Series E Preferred Stock outstanding. Dividends, when, as and if declared by the Board of Directors, shall be paid out of funds at the time legally available for such purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series F preferred stock issued for services</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Series F Preferred Stock is subordinated to our common stock and superior to all shares of Preferred Stock. It does not receive dividends and does not participate in equity distributions. <span id="xdx_90A_eus-gaap--PreferredStockVotingRights_c20230201__20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zzEMJvVJFqJk" title="Description of voting rights">The Series F Preferred stock retains 2/3 of the voting rights in the company.</span> During the year ended January 31, 2021, the Company issued <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zU1ijjW3VbH5" title="Preferred stock, issued">1,000,000</span> shares of Series F Preferred Stock to Sydney Jim, our CEO, in exchange for services. As of the date of this report, there are <span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20210131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zBzJeyufcAu4" title="Preferred stock, outstanding">1,000,000</span> shares Series F Preferred Stock outstanding. As of October 31, 2023, and January 31, 2023, there are <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_z7GEcopwB98a" title="Preferred stock, outstanding"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20230131__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesFPreferredStockMember_zmLPu70NGfG5" title="Preferred stock, outstanding">1,000,000</span></span> shares of Series F Preferred Stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Series G convertible preferred stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended October 31, 2023, the Company the holder of the Series G convertible preferred stock converted <span id="xdx_90C_ecustom--PreferedStockConvertedIntoCommonStock1_iI_pid_uShares_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_ze5LHPyFMJOi" title="Prefered stock converted into common stock">35,200</span> shares and accrued dividends of $<span id="xdx_901_ecustom--DividendsPayableCurrentAndNoncurrent1_iI_pp0p0_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z5JNhqNh0i4g" title="Accrured dividends">1,408</span> into <span id="xdx_905_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20231031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zfP8McmBrqNj">174,323,810</span> shares of common stock. During the nine months ended October 31, 2022, the Company accrued dividends of $<span id="xdx_908_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pid_c20221031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_z9gGfyhTkGn1" title="Dividends payable">3,532</span>, and the holder of the Series G convertible preferred stock converted <span id="xdx_906_ecustom--PreferedStockConvertedIntoCommonStock1_iI_pid_uShares_c20221031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zETp7PApskCf">250,000</span> shares and accrued dividends of $<span id="xdx_90A_ecustom--DividendsPayableCurrentAndNoncurrent1_iI_pid_c20221031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zQvuCcavzPYe">10,000</span> into <span id="xdx_904_ecustom--PreferedStockConvertedIntoCommonStock_iI_pid_uShares_c20221031__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zDR9fp3QJhUe">518,644,372</span> shares of common stock. The conversions were in accordance with the terms of the agreement and no gain or loss was recognized. As of October 31, 2023, there were no shares of Series G convertible preferred stock outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Preferred Stock Subscription</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 23, 2022, the Company sold <span id="xdx_90A_eus-gaap--PreferredStockShareSubscriptions_iI_pid_uShares_c20220223_zxB3MCe4KPJj" title="Number of shares sold">10,000</span> shares of preferred stock not yet designated for cash proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_c20220221__20220223_zxHWfZdaSgCa" title="Cash proceeds">50,000</span>.</p> 50000 5 0.10 800 50000 50000 10000 5 0.004 800 10000 50000 10000 10000 40000 5 0.10 500000 0.01 38 40000 200000 40000 40000 1000000 The Series E Preferred stock has 2 votes for each outstanding share of common stock in the company. 1000000 1000000 The Series F Preferred stock retains 2/3 of the voting rights in the company. 1000000 1000000 1000000 1000000 35200 1408 174323810 3532 250000 10000 518644372 10000 50000 EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 179 156 1 false 17 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://neutracorp.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 00000008 - Disclosure - Background Information Sheet http://neutracorp.com/role/BackgroundInformation Background Information Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://neutracorp.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Significant Accounting Policies Sheet http://neutracorp.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 10 false false R11.htm 00000011 - Disclosure - Property and equipment, net Sheet http://neutracorp.com/role/PropertyAndEquipmentNet Property and equipment, net Notes 11 false false R12.htm 00000012 - Disclosure - Related Party Transactions Sheet http://neutracorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 00000013 - Disclosure - Advances and Notes Payable Notes http://neutracorp.com/role/AdvancesAndNotesPayable Advances and Notes Payable Notes 13 false false R14.htm 00000014 - Disclosure - Shareholders??? Equity Sheet http://neutracorp.com/role/ShareholdersEquity Shareholders??? Equity Notes 14 false false R15.htm 00000015 - Disclosure - Significant Accounting Policies (Policies) Sheet http://neutracorp.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://neutracorp.com/role/SignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Property and equipment, net (Tables) Sheet http://neutracorp.com/role/PropertyAndEquipmentNetTables Property and equipment, net (Tables) Tables http://neutracorp.com/role/PropertyAndEquipmentNet 16 false false R17.htm 00000017 - Disclosure - Going Concern (Details Narrative) Sheet http://neutracorp.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://neutracorp.com/role/GoingConcern 17 false false R18.htm 00000018 - Disclosure - Significant Accounting Policies (Details Narrative) Sheet http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative Significant Accounting Policies (Details Narrative) Details http://neutracorp.com/role/SignificantAccountingPoliciesPolicies 18 false false R19.htm 00000019 - Disclosure - Property and equipment consist of the following: (Details) Sheet http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails Property and equipment consist of the following: (Details) Details 19 false false R20.htm 00000020 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://neutracorp.com/role/RelatedPartyTransactions 20 false false R21.htm 00000021 - Disclosure - Advances and Notes Payable (Details Narrative) Notes http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative Advances and Notes Payable (Details Narrative) Details http://neutracorp.com/role/AdvancesAndNotesPayable 21 false false R22.htm 00000022 - Disclosure - Shareholders??? Equity (Details Narrative) Sheet http://neutracorp.com/role/ShareholdersEquityDetailsNarrative Shareholders??? Equity (Details Narrative) Details http://neutracorp.com/role/ShareholdersEquity 22 false false All Reports Book All Reports form_10-q.htm ntrr-20231031.xsd ntrr-20231031_cal.xml ntrr-20231031_def.xml ntrr-20231031_lab.xml ntrr-20231031_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 39 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form_10-q.htm": { "nsprefix": "ntrr", "nsuri": "http://neutracorp.com/20231031", "dts": { "inline": { "local": [ "form_10-q.htm" ] }, "schema": { "local": [ "ntrr-20231031.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "ntrr-20231031_cal.xml" ] }, "definitionLink": { "local": [ "ntrr-20231031_def.xml" ] }, "labelLink": { "local": [ "ntrr-20231031_lab.xml" ] }, "presentationLink": { "local": [ "ntrr-20231031_pre.xml" ] } }, "keyStandard": 121, "keyCustom": 35, "axisStandard": 7, "axisCustom": 0, "memberStandard": 12, "memberCustom": 5, "hidden": { "total": 144, "http://fasb.org/us-gaap/2023": 98, "http://neutracorp.com/20231031": 41, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 179, "entityCount": 1, "segmentCount": 17, "elementCount": 251, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 483, "http://xbrl.sec.gov/dei/2023": 27 }, "report": { "R1": { "role": "http://neutracorp.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://neutracorp.com/role/ConsolidatedBalanceSheets", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R3": { "role": "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "unique": true } }, "R4": { "role": "http://neutracorp.com/role/ConsolidatedStatementsOfOperations", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-08-012023-10-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-08-012023-10-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R5": { "role": "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-01-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-02-012022-04-30_us-gaap_CommonStockMember", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "unique": true } }, "R6": { "role": "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "longName": "00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED)", "shortName": "CONSOLIDATED STATEMENT OF CHANGES IN MEZZANINE EQUITY (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "AsOf2023-01-31_us-gaap_SeriesGPreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-01-31_us-gaap_SeriesGPreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R7": { "role": "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "unique": true } }, "R8": { "role": "http://neutracorp.com/role/BackgroundInformation", "longName": "00000008 - Disclosure - Background Information", "shortName": "Background Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://neutracorp.com/role/GoingConcern", "longName": "00000009 - Disclosure - Going Concern", "shortName": "Going Concern", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://neutracorp.com/role/SignificantAccountingPolicies", "longName": "00000010 - Disclosure - Significant Accounting Policies", "shortName": "Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://neutracorp.com/role/PropertyAndEquipmentNet", "longName": "00000011 - Disclosure - Property and equipment, net", "shortName": "Property and equipment, net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://neutracorp.com/role/RelatedPartyTransactions", "longName": "00000012 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://neutracorp.com/role/AdvancesAndNotesPayable", "longName": "00000013 - Disclosure - Advances and Notes Payable", "shortName": "Advances and Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://neutracorp.com/role/ShareholdersEquity", "longName": "00000014 - Disclosure - Shareholders\u2019 Equity", "shortName": "Shareholders\u2019 Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies", "longName": "00000015 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "15", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "ntrr:InterimFinancialStatementsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "ntrr:InterimFinancialStatementsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://neutracorp.com/role/PropertyAndEquipmentNetTables", "longName": "00000016 - Disclosure - Property and equipment, net (Tables)", "shortName": "Property and equipment, net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "16", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://neutracorp.com/role/GoingConcernDetailsNarrative", "longName": "00000017 - Disclosure - Going Concern (Details Narrative)", "shortName": "Going Concern (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "17", "firstAnchor": { "contextRef": "From2023-08-012023-10-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": null }, "R18": { "role": "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative", "longName": "00000018 - Disclosure - Significant Accounting Policies (Details Narrative)", "shortName": "Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "18", "firstAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:InventoryValuationReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InventoryFinishedGoodsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-01-31", "name": "us-gaap:InventoryValuationReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:InventoryValuationReserves", "span", "span", "p", "us-gaap:InventoryFinishedGoodsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "unique": true } }, "R19": { "role": "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "longName": "00000019 - Disclosure - Property and equipment consist of the following: (Details)", "shortName": "Property and equipment consist of the following: (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "19", "firstAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "00000020 - Disclosure - Related Party Transactions (Details Narrative)", "shortName": "Related Party Transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "From2023-02-01to2023-10-31", "name": "ntrr:ExpensesPaidOnCompanysBehalf", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-03-11", "name": "ntrr:MonthlyInterestPayment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "unique": true } }, "R21": { "role": "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "longName": "00000021 - Disclosure - Advances and Notes Payable (Details Narrative)", "shortName": "Advances and Notes Payable (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "AsOf2023-10-31", "name": "ntrr:AdvancesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-03-11", "name": "ntrr:MonthlyIntrestPayment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "unique": true } }, "R22": { "role": "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "longName": "00000022 - Disclosure - Shareholders\u2019 Equity (Details Narrative)", "shortName": "Shareholders\u2019 Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "AsOf2023-10-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-02-23", "name": "us-gaap:PreferredStockShareSubscriptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "form_10-q.htm", "unique": true } } }, "tag": { "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment, net", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r5", "r81", "r84", "r260" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation", "label": "Depreciation [Default Label]", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r27" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayable" ], "lang": { "en-us": { "role": { "label": "Advances and Notes Payable", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r67", "r116", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184" ] }, "ntrr_SeriesGPreferredStockConvertedToCommonStock1": { "xbrltype": "sharesItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "SeriesGPreferredStockConvertedToCommonStock1", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity" ], "lang": { "en-us": { "role": { "label": "Series G Preferred Stock Converted to Common Stock", "documentation": "The element represents series g preferred stock converted to common stock1." } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "auth_ref": [ "r119", "r210", "r211", "r212", "r213", "r238", "r368", "r424", "r427", "r428" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r393" ] }, "ntrr_RevenueObligationBeforePercentage": { "xbrltype": "percentItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "RevenueObligationBeforePercentage", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue obligation from Deity Corporation before sales threshold, percentage" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r398" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r407" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r392" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "verboseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r65", "r81", "r84", "r85" ] }, "ntrr_SeriesGPreferredStockConvertedToCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "SeriesGPreferredStockConvertedToCommonStock", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity" ], "lang": { "en-us": { "role": { "label": "Series G preferred stock converted to common stock", "documentation": "The element represents series g preferred stock converted to common stock." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r397" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r50", "r71", "r258", "r269", "r270", "r276", "r303", "r377" ] }, "ntrr_FinancingReceivableAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "FinancingReceivableAccruedInterest", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued interest" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ntrr_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "WorkingCapital", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital", "documentation": "The element represents working capital." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r396" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Valuation allowance recognized", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r26", "r414" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued interest payable", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "ntrr_DividendsOnSeriesGConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "DividendsOnSeriesGConvertiblePreferredStock", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Dividends on Series G convertible preferred stock" } } }, "auth_ref": [] }, "us-gaap_DividendsPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPreferredStock", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends on Series G convertible preferred stock", "label": "Dividends, Preferred Stock", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r2", "r71" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable to related party", "label": "Increase (Decrease) in Accounts Payable, Related Parties", "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "ntrr_MonthlyIntrestPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "MonthlyIntrestPayment", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Monthly intrest payment", "documentation": "The element represents monthly intrest payment." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable to related party", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r7", "r377" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "ntrr_OperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r4", "r27" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r202", "r235", "r236", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r295", "r296", "r297", "r298", "r299", "r319", "r321", "r353", "r433" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r11", "r92", "r118", "r161", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r211", "r212", "r213", "r223", "r377", "r425", "r434", "r435" ] }, "ntrr_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average shares outstanding - basic and diluted", "documentation": "The element represents total weighted average number of share outstanding basic and diluted." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r392" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r66" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r30", "r31", "r32", "r33", "r34", "r35", "r36", "r69", "r70", "r71", "r97", "r98", "r99", "r141", "r186", "r187", "r188", "r190", "r193", "r198", "r200", "r272", "r273", "r274", "r275", "r376", "r410", "r416" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r97", "r98", "r99", "r141", "r186", "r187", "r188", "r190", "r193", "r198", "r200", "r272", "r273", "r274", "r275", "r376", "r410", "r416" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r111" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r38", "r39" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r60", "r61", "r62" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r422", "r432" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r404" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://neutracorp.com/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r68", "r117", "r185", "r187", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r199", "r201", "r220", "r349", "r351", "r366" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOW FROM OPERATING ACTIVITIES:" } } }, "auth_ref": [] }, "ntrr_RevenueObligationAfterPercentage": { "xbrltype": "percentItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "RevenueObligationAfterPercentage", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue obligation from Deity Corporation after sales threshold, percentage" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r9", "r118", "r161", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r211", "r212", "r213", "r223", "r300", "r374", "r389", "r425", "r434", "r435" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r409" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r404" ] }, "us-gaap_SalariesAndWages": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalariesAndWages", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Salary expense", "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold." } } }, "auth_ref": [ "r415" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r47", "r186" ] }, "ntrr_OtherLiabilityCurrentRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "OtherLiabilityCurrentRelatedParty", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts payable - related party", "documentation": "The element represents other liability current related party." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r403" ] }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of Series G convertible preferred stock", "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [ "r1" ] }, "ntrr_RevenueObligationThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "RevenueObligationThreshold", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue obligation from Deity Corporation sales threshold" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r48" ] }, "us-gaap_PreferredStockShareSubscriptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockShareSubscriptions", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares sold", "documentation": "The number of nonredeemable preferred stock (shares) (or preferred stock redeemable solely at the option of the issuer) allocated to investors to buy shares of a new issue of preferred stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds." } } }, "auth_ref": [ "r47" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r403" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dividends payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r45", "r46", "r73", "r386", "r436" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r422" ] }, "ntrr_ConversionofSeriesGpreferredstock": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "ConversionofSeriesGpreferredstock", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of Series G preferred stock", "documentation": "The element represents conversionof series G preferred stock." } } }, "auth_ref": [] }, "ntrr_DividendsPayableCurrentAndNoncurrent1": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "DividendsPayableCurrentAndNoncurrent1", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrured dividends", "documentation": "The element represents dividends payable current and noncurrent1." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r110", "r112", "r113" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r47", "r302" ] }, "ntrr_ProceedsFromAdvanceFromRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "ProceedsFromAdvanceFromRelatedParty", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from advance from related party", "verboseLabel": "Investor advance", "documentation": "The element represents proceeds from advance from related party." } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r47", "r302", "r320", "r439", "r440" ] }, "ntrr_PreferedStockConvertedIntoCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "PreferedStockConvertedIntoCommonStock", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prefered stock converted into common stock", "documentation": "The element represents prefered stock converted into common stock." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfDebt", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash proceeds", "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings." } } }, "auth_ref": [] }, "ntrr_StockSubscriptionsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "StockSubscriptionsReceived", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock subscriptions received", "documentation": "The element represents stock subscriptions received." } } }, "auth_ref": [] }, "us-gaap_PreferredStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockVotingRights", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of voting rights", "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r33", "r47" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r53", "r74", "r259", "r377", "r417", "r423", "r431" ] }, "us-gaap_CostsAndExpensesRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesRelatedParty", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Commission expense", "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties." } } }, "auth_ref": [ "r57" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r403" ] }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies." } } }, "auth_ref": [ "r29", "r367" ] }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash proceeds", "label": "Proceeds from Issuance of Preferred Stock and Preference Stock", "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation." } } }, "auth_ref": [ "r1" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r13", "r43", "r255", "r301" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r390" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Noncash investing and financing transactions:" } } }, "auth_ref": [] }, "ntrr_DeemedDividendOnSeriesGPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "DeemedDividendOnSeriesGPreferredStock", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Dividends on Series G preferred stock", "documentation": "The element represents deemed dividend on series g preferred stock." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r406" ] }, "ntrr_UnsecuredLoanIntrest": { "xbrltype": "percentItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "UnsecuredLoanIntrest", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unsecured loan interest", "verboseLabel": "Unsecured loan intrest", "documentation": "The element represents unsecured loan intrest." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsPolicyPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Subsequent events", "documentation": "Disclosure of accounting policy for reporting subsequent events." } } }, "auth_ref": [] }, "us-gaap_SeriesFPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesFPreferredStockMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series F Preferred Stock [Member]", "documentation": "Series F preferred stock." } } }, "auth_ref": [ "r412", "r413", "r429" ] }, "ntrr_DeemedDividendOnMezzanineEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "DeemedDividendOnMezzanineEquity", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deemed dividend on mezzanine equity" } } }, "auth_ref": [] }, "us-gaap_SeriesCPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesCPreferredStockMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series C Preferred Stock [Member]", "documentation": "Series C preferred stock." } } }, "auth_ref": [ "r412", "r413", "r429" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r202", "r235", "r236", "r295", "r296", "r297", "r298", "r299", "r319", "r321", "r353" ] }, "us-gaap_SeriesEPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesEPreferredStockMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series E Preferred Stock [Member]", "documentation": "Series E preferred stock." } } }, "auth_ref": [ "r412", "r413", "r429" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET CHANGE IN CASH AND CASH EQUIVALENTS", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r60" ] }, "ntrr_InterimFinancialStatementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "InterimFinancialStatementsPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Interim Financial Statements", "documentation": "The element represents interim financial statements policy text block." } } }, "auth_ref": [] }, "us-gaap_SeriesGPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesGPreferredStockMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series G Preferred Stock [Member]", "documentation": "Series G preferred stock." } } }, "auth_ref": [ "r412", "r413", "r429" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r63", "r115" ] }, "us-gaap_LongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermNotesPayable", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes payable, related party", "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r12" ] }, "ntrr_DividendsOnMezzanineEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "DividendsOnMezzanineEquity", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends on mezzanine equity" } } }, "auth_ref": [] }, "ntrr_LoanAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "LoanAgreement", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan agreement", "documentation": "The element represents loan agreement." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued for preferred stock conversions", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r6", "r47", "r48", "r71", "r280", "r346", "r362", "r388" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings (Loss) per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r20", "r21" ] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r412", "r413", "r429" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r18", "r60", "r114" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r55", "r118", "r143", "r149", "r153", "r155", "r161", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r223", "r375", "r425" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "ntrr_EarningsLossPerShareBasicAndDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "EarningsLossPerShareBasicAndDiluted", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per common share", "documentation": "The element represents earnings loss per share basic and diluted." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r48" ] }, "us-gaap_CumulativeDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CumulativeDividends", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cumulative dividends received", "documentation": "Amount of cumulative cash dividends distributed to shareholders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued for preferred stock conversions (in shares)", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r6", "r47", "r48", "r71", "r272", "r346", "r362" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r41", "r42", "r326", "r327", "r330" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r232", "r233", "r234", "r236", "r237", "r277", "r278", "r279", "r328", "r329", "r330", "r350", "r352" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "ntrr_OperatingIncomeExpense", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r58", "r325" ] }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationPercentage", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue, remaining performance obligation, percentage", "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue." } } }, "auth_ref": [ "r411" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.001 par value; unlimited shares authorized; 2,917,899,124 and 2,743,575,314 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r48", "r257", "r377" ] }, "ntrr_RecentlyAdoptedAccountingPronouncementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "RecentlyAdoptedAccountingPronouncementsPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Adopted Accounting Pronouncements", "documentation": "The element represents recently adopted accounting pronouncements policy text block." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r72", "r96", "r118", "r143", "r150", "r154", "r161", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r210", "r212", "r223", "r254", "r314", "r377", "r389", "r425", "r426", "r434" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r326", "r327", "r330" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, value", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r47", "r256", "r377" ] }, "ntrr_MezzanineEquityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "MezzanineEquityPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Mezzanine equity", "documentation": "The element represents mezzanine equity policy text block." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r6", "r48", "r302", "r320", "r439", "r440" ] }, "ntrr_MonthlyInterestPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "MonthlyInterestPayment", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Monthly interest payment" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss before income taxes", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r143", "r149", "r153", "r155", "r264", "r375" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayments on notes payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r17" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)" } } }, "auth_ref": [] }, "ntrr_ExpensesPaidOnCompanysBehalf": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "ExpensesPaidOnCompanysBehalf", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expenses paid on the Company\u2019s behalf", "verboseLabel": "Expenses paid", "documentation": "The element represents expenses paid on companys behalf." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r88", "r97", "r98", "r99", "r118", "r134", "r135", "r138", "r139", "r141", "r142", "r161", "r165", "r167", "r168", "r169", "r172", "r173", "r186", "r187", "r190", "r193", "r200", "r223", "r272", "r273", "r274", "r275", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r302", "r323", "r346", "r361", "r362", "r363", "r364", "r365", "r410", "r416", "r421" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails" ], "lang": { "en-us": { "role": { "label": "Total property and equipment", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r66", "r94", "r262" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense)", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r59" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL STOCKHOLDERS' DEFICIT", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r48", "r51", "r52", "r64", "r304", "r320", "r347", "r348", "r377", "r389", "r417", "r423", "r431", "r439" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r253", "r262", "r377" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "ntrr_UnpaidCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "UnpaidCompensation", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued commission", "documentation": "The element represents unpaid compensation." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r77", "r86", "r130", "r131", "r147", "r206", "r209", "r265" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r203", "r204", "r205", "r280", "r418", "r419", "r420", "r430", "r439" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_SalesCommissionsAndFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesCommissionsAndFees", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "ntrr_OperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Sales commissions", "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller)." } } }, "auth_ref": [ "r58" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r91", "r101", "r118", "r161", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r210", "r212", "r223", "r377", "r425", "r426", "r434" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r392" ] }, "us-gaap_PreferredStockSharesSubscribedButUnissuedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesSubscribedButUnissuedValue", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock subscribed but not issued", "documentation": "Amount of subscription received from investors who have been allocated nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r47" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableAccruedInterestWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableAccruedInterestWriteoff", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued interest", "label": "Financing Receivable, Accrued Interest, Writeoff", "documentation": "Amount of writeoff of accrued interest on financing receivable recognized by reversing interest income." } } }, "auth_ref": [ "r164" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of note payable", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r16" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r120", "r121", "r122", "r140", "r239", "r271", "r291", "r294", "r295", "r296", "r297", "r298", "r299", "r302", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r315", "r316", "r317", "r318", "r319", "r321", "r324", "r325", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r346", "r381" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoodsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsPolicy", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory Finished Goods, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory awaiting sale (finished goods). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average)." } } }, "auth_ref": [ "r25" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r392" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ntrr_PreferredStockSharesOutstanding1": { "xbrltype": "sharesItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "PreferredStockSharesOutstanding1", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares outstanding", "documentation": "The element represents preferred stock shares outstanding1." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r401", "r403", "r404" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "verboseLabel": "Preferred stock subscribed but not issued", "label": "Stock Issued During Period, Value, Issued for Services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r402" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r6", "r15", "r89", "r104", "r105", "r106", "r120", "r121", "r122", "r124", "r129", "r131", "r140", "r162", "r163", "r201", "r203", "r204", "r205", "r207", "r208", "r214", "r215", "r216", "r217", "r218", "r219", "r221", "r224", "r225", "r226", "r227", "r228", "r229", "r231", "r266", "r267", "r268", "r280", "r346" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r100", "r371", "r377" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://neutracorp.com/role/GoingConcern" ], "lang": { "en-us": { "role": { "label": "Going Concern", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r44" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r89", "r120", "r121", "r122", "r124", "r129", "r131", "r162", "r163", "r203", "r204", "r205", "r207", "r208", "r214", "r216", "r217", "r219", "r221", "r266", "r268", "r280", "r439" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r405" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r404" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r88", "r97", "r98", "r99", "r118", "r134", "r135", "r138", "r139", "r141", "r142", "r161", "r165", "r167", "r168", "r169", "r172", "r173", "r186", "r187", "r190", "r193", "r200", "r223", "r272", "r273", "r274", "r275", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r302", "r323", "r346", "r361", "r362", "r363", "r364", "r365", "r410", "r416", "r421" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r6", "r89", "r104", "r105", "r106", "r120", "r121", "r122", "r124", "r129", "r131", "r140", "r162", "r163", "r201", "r203", "r204", "r205", "r207", "r208", "r214", "r215", "r216", "r217", "r218", "r219", "r221", "r224", "r225", "r226", "r227", "r228", "r229", "r231", "r266", "r267", "r268", "r280", "r346" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r392" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r392" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r378", "r379", "r380", "r382", "r383", "r384", "r385", "r418", "r419", "r430", "r437", "r439" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r392" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the period for:" } } }, "auth_ref": [] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r412", "r413", "r429" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r403" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r408" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r56", "r239" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r391" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "Property and equipment consist of the following:", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r119", "r210", "r211", "r212", "r213", "r238", "r368", "r424", "r427", "r428" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r400" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r19" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r47", "r186" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidated Financial Statements", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r37", "r372" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r18", "r93", "r370" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ntrr_StockSubscribedButNotIssuedMember": { "xbrltype": "domainItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "StockSubscribedButNotIssuedMember", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Subscribed but Not Issued [Member]", "documentation": "The element represents stock subscribed but not issued member." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r394" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r395" ] }, "ntrr_DeityCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "DeityCorporationMember", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deity Corporation [Member]", "documentation": "The element represents deity corporation member." } } }, "auth_ref": [] }, "ntrr_MrJimMember": { "xbrltype": "domainItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "MrJimMember", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr Jim [Member]", "documentation": "The element represents mr jim member." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r399" ] }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedBalancePrincipalAmount", "crdr": "debit", "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Principal balance", "verboseLabel": "Loan agreement", "documentation": "Amount of principal of investment owned." } } }, "auth_ref": [ "r292", "r293", "r355", "r358", "r360", "r380" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows", "http://neutracorp.com/role/ConsolidatedStatementsOfOperations", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://neutracorp.com/role/GoingConcernDetailsNarrative" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "negatedLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r54", "r62", "r75", "r90", "r102", "r103", "r106", "r118", "r123", "r125", "r126", "r127", "r128", "r130", "r131", "r136", "r143", "r149", "r153", "r155", "r161", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r222", "r223", "r263", "r322", "r344", "r345", "r375", "r387", "r425" ] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Dividends payable on Series G preferred stock", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r10" ] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquipmentMember", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails", "http://neutracorp.com/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services." } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r120", "r121", "r122", "r140", "r239", "r271", "r291", "r294", "r295", "r296", "r297", "r298", "r299", "r302", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r315", "r316", "r317", "r318", "r319", "r321", "r324", "r325", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r346", "r381" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r109", "r125", "r126", "r127", "r128", "r132", "r133", "r137", "r139", "r143", "r149", "r153", "r155", "r375" ] }, "ntrr_AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "AccountsPayableRelatedPartyAndAdvancesPayableToRelatedPartyMember", "presentation": [ "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Payable Related Party and Advances Payable to Related Party [Member]", "documentation": "The element represents accounts payable related party and advances payable to related party member." } } }, "auth_ref": [] }, "ntrr_VIVISCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "VIVISCorporationMember", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "VIVIS Corporation [Member]", "documentation": "The element represents v i v i s corporation member." } } }, "auth_ref": [] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://neutracorp.com/role/BackgroundInformation" ], "lang": { "en-us": { "role": { "label": "Background Information", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r78", "r87" ] }, "ntrr_AdvancesPayableToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "AdvancesPayableToRelatedParty", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets", "http://neutracorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advances payable to related party", "documentation": "The element represents advances payable to related party." } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendRatePercentage", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, dividend rate, percentage", "documentation": "The percentage rate used to calculate dividend payments on preferred stock." } } }, "auth_ref": [ "r187", "r354", "r356", "r357", "r359" ] }, "ntrr_AdvancesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "AdvancesPayable", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/AdvancesAndNotesPayableDetailsNarrative", "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Advances payable", "documentation": "The element represents advances payable." } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r324", "r369", "r373" ] }, "us-gaap_CommonStockSharesAuthorizedUnlimited": { "xbrltype": "authorizedUnlimitedItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorizedUnlimited", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized, unlimited", "documentation": "Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is \"Unlimited\"." } } }, "auth_ref": [ "r14" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "REVENUE", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r108", "r118", "r144", "r145", "r148", "r151", "r152", "r156", "r157", "r158", "r161", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r223", "r252", "r425" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "LOSS FROM OPERATIONS", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r143", "r149", "r153", "r155", "r375" ] }, "ntrr_MezzanineEquityAbstract": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "MezzanineEquityAbstract", "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "MEZZANINE EQUITY" } } }, "auth_ref": [] }, "ntrr_SeriesGPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "SeriesGPreferredStock", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Series G preferred stock; $1.00 stated value, 0 shares and 35,200 shares issued and outstanding at October 31, 2023 and January 31, 2023, respectively", "documentation": "The element represents series g preferred stock." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/PropertyAndEquipmentConsistOfFollowingDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r28", "r95", "r261" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementOfChangesInMezzanineEquity", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "ntrr_OperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "OperatingIncomeExpense", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total operating expenses", "documentation": "The element represents operating income expense.", "label": "Operating Income Expense" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInterestPayableNet", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued interest payable", "label": "Increase (Decrease) in Interest Payable, Net", "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertiblePreferredStockMember", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Preferred Stock [Member]", "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option." } } }, "auth_ref": [ "r186", "r187", "r190", "r382", "r383", "r384", "r385" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts Receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "ntrr_DeemedDividendOnSeriesGConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "DeemedDividendOnSeriesGConvertiblePreferredStock", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations", "http://neutracorp.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Deemed dividend on Series G convertible preferred stock", "documentation": "The element represents deemed dividend on series g convertible preferred stock." } } }, "auth_ref": [] }, "ntrr_PreferedStockConvertedIntoCommonStock1": { "xbrltype": "sharesItemType", "nsuri": "http://neutracorp.com/20231031", "localname": "PreferedStockConvertedIntoCommonStock1", "presentation": [ "http://neutracorp.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Prefered stock converted into common stock", "documentation": "The element represents prefered stock converted into common stock1.", "label": "Prefered Stock Converted into Common Stock" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r159", "r160" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://neutracorp.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r22", "r23", "r24", "r79", "r80", "r82", "r83" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r3" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://neutracorp.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r40", "r76", "r107", "r146", "r230", "r331", "r387", "r438" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://neutracorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://neutracorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r49" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://neutracorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3D" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "450", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r370": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r373": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r374": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r375": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r376": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r377": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r378": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r380": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r386": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r388": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r389": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r390": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r391": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r392": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r394": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r396": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r397": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r398": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r399": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r400": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r401": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r402": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r403": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r404": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r405": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r407": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r408": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r409": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r410": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 40 0001161697-23-000627-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001161697-23-000627-xbrl.zip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Ĵ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